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Abstract
In order to understand the substrate specificity of protein tyrosine phosphatase-like myo-
inositol phosphatases (PTPLPs), I have determined the structure of PhyA fromMitsuokella
multacida (PhyAmm) and Selenomonas ruminantium (PhyAsr) in complex with multiple
myo-inositol phosphates (IPs). These are the first atomic resolution structures of PTPLPs
in complex with InsP5, InsP4, or InsP3 substrates, and represent four of the five known
PTPLP:IP complex structures. Based on these structures, I have identified three struc-
tural features that determine the substrate specificity of PTPLPs. As part of this work, I
demonstrate that the PhyAmm C-terminal repeat and PhyAsr bind substrates using con-
served phosphoryl-binding sites. Further, I have determined the InsP6 hydrolysis pathways
for several PTPLPs and present a novel IP specificity assay. With this assay, I identify that
the two repeats of PhyAmm have divergent activities that clearly indicate a “divide and
conquer” approach to maximize phosphoryl group removal from InsP6 and mixed IPs.
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Chapter 1
Literature Review
1.1 myo-inositol
Inositol is a cyclic carbohydrate with hydroxyl groups attached to the six carbons of the
ring (Figure 1.1). myo-inositol is the stereoisomer most often used in biology where one
hydroxyl is in the axial position and the other five are equatorial in the lowest energy chair
conformation [1, 2]. myo-inositol is also known as meso-inositol as it has a plane of sym-
metry through the C2 and C5 atoms [3]. The remaining atoms are prochiral pairs (C1/C3
and C4/C6) and numbers can be assigned relative to C2 in either the D- or L- configuration
(Figure 1.1). Generally, unless the L- configuration is specified, the abbreviation Ins is re-
garded as myo-inositol in the D- configuration as per IUPAC recommendations. Since the
original isolation of myo-inositol in 1850, it has been shown to have a central role in cellu-
lar metabolism [4,5]. myo-inositol is now known to be ubiquitous in eukaryotes, present in
many archaea, and within a few bacteria [2, 3, 6–8]. myo-inositol is present in the cells as a
variety of derivatives including myo-inositol phosphates (IPs) [5].
1.2 myo-inositol phosphates
In 1872, Pfeffer demonstrated that an organic phosphate salt was present in wheat grain
which was later identified to contain myo-inositol and phosphate [9–12]. The different
phosphorylation levels of myo-inositol phosphates (IPs) were indistinguishable leading to
all IPs being referred to as phytic acid or phytin, where phytin refers to IPs in the salt
form [13, 14]. In 1951, the heterogeneity of phytic acid was revealed by the application of
1
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Figure 1.1: Ball and stick diagram of myo-inositol in the energetically favoured chair con-
formation with five equatorial and one axial hydroxyl group, carbon is in grey and oxygen
in red. myo-inositol has a plane of symmetry that rotates the structure about C2 and C5
as fixed positions. The remaining positions are two prochiral pairs: C1/C3 and C4/C6.
When numbered clockwise (inside the ring) the assigned number on carbon 1 is 1L. When
numbered counterclockwise (outside the ring) the assigned number is 1D. Generally, the
abbreviation Ins should be reguarded as myo-inositol in the D- configuration, unless the L-
configuration is specified.
ion exchange procedures and later shown to included a mixture of IPs and esters of inositols
other than myo-inositol [10, 15, 16]. In 1962, experiments following phytate formation
during rice grain maturation demonstrated that levels of phosphoinositides (PIs), IPs, and
myo-inositol fluctuate [17].
Since their initial discovery, phosphorylated myo-inositols containing from one to eight
phosphoryl groups have been identified and many have demonstrated biological activ-
ity [2, 18, 19]. In general, highly-phosphorylated IPs serve as cofactors, whereas less-
phosphorylated IPs are utilized as second messengers in signal transduction pathways.
Less-abundant IPs are difficult to detect and identify at sub-micromolar concentrations and
novel functional roles are still being discovered [20,21]. IPs are particularly challenging to
purify or synthesize and only a small subset of known IPs are commercially available [22].
Consequently, improved methods for producing, detecting, and identifying IPs are likely to
lead to additional discoveries regarding the biological roles of this family of metabolites.
2
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1.2.1 myo-inositol-1,2,3,4,5,6-hexakisphosphate
myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP6 or phytic acid) is the most abundant
phosphorylatedmyo-inositol derivative (Figure 1.2) [23]. First identified as a storage source
for myo-inositol and inorganic phosphate in seeds, InsP6 has since been shown to have
multiple roles in the cellular processes such as regulating plant hormone receptors, iron
transport, translation, DNA repair, RNA processing, mRNA export, plant development,
apoptosis, and pathogenicity [3,17,24–32]. The importance of InsP6 in cells is emphasized
by the observation that deletion of enzymes involved in InsP6 biosynthesis has a lethal
phenotype in mouse embryos [33, 34].
Figure 1.2: Ball and stick diagram of myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP6 or
phytic acid) in the energetically favoured chair conformation with five equatorial and one
axial phosphoryl group, carbon is in grey, oxygen in red and phosphorus in orange. InsP6
has a plane of symmetry that rotates the structure about the C2 and C5 as fixed positions.
The remaining positions are two prochiral pairs: C1/C3 and C4/C6. When numbered clock-
wise (inside the ring) the assigned number on carbon 1 is 1L.When numbered counterclock-
wise (outside the ring) the assigned number is 1D. Generally, the abbreviation Ins should
be regarded as myo-inositol in the D- configuration, unless otherwise specified in the L-
configuration.
The structure of InsP6 was given in 1907 and later confirmed with
31P-NMR [11, 14,
35, 36]. Subsequently, it was determined that InsP6 in solution preferentially adopts the
five equatorial and one axial phosphoryl group conformation [37, 38]. InsP6 undergoes a
3
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conformational inversion between pH 9.2 and 9.6 from the five equatorial and one axial
conformation (pH<9.2) to one equatorial and five axial phosphoryl groups (pH>9.6) [38].
Between pH 9.2 and 9.6 InsP6 is in dynamic equilibrium, likely caused by the associa-
tion/dissociation of one or multiple of the least acidic protons [38]. InsP6 has twelve sites
that can be protonated across the six phosphoryl groups [37, 38]. Of the twelve sites, six
are strongly acidic with pKa values between 1.1 and 2.1, three sites are slightly acidic with
pKa values between 6.0 to 7.6 and the last three are weakly acidic with pKa values between
9.2 and 9.6 [37, 38]. The pKa values are dependent on the counter-ion present and their
concentration in solution as InsP6 is a strong chelator [38–41]. More recent studies demon-
strate the preferred chair conformation of less-phosphorylated IPs and the pH at which they
undergo conformational inversion is unique to the particular isomer [42].
1.2.2 myo-inositol pentakisphosphate
When the method to resolve different IPs was discovered, the presence of myo-inositol
pentakisphosphate (InsP5) was identified in soil samples [16]. Subsequently, myo-inositol-
1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) was shown to be the most abundant IP in
avian erythrocytes where it functions as a hemoglobin effector [14, 43–45]. Following the
identification the role of myo-inositol-1,4,5-trikisphosphate (Ins(1,4,5)P3) as a releaser of
intracellular calcium (discussed below), the presence of Ins(1,3,4,5,6)P5 was identified in
pituitary cells and found to respond to hormone stimulation [46, 47]. As methods were de-
veloped to distinguish between the different InsP5 isomers, they were shown to respond to
hormone signaling, affect rates of cell proliferation, modulate apoptotic responses, regulate
viral assembly, chromatin remodeling, calcium channel activity, cytoskeleton reorganiza-
tion, function as a hemoglobin effector, and functions as a precursor to several metabo-
lites [18, 45, 47–57].
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1.2.3 myo-inositol tetrakisphosphate and myo-inositol trikisphosphate
Generally, the less-phosphorylated IPs,myo-inositol tetrakisphosphate (InsP4) andmyo-
inositol trikisphosphate (InsP3), function as second messengers. Discovery of their role in
signal transduction pathways followed work demonstrating that the cleavage of phospho-
inositol stimulated calcium release, leading to the identification of Ins(1,4,5)P3 as a second
messenger in 1983 [46, 58, 59]. In this calcium mobilizing pathway, phosphatidylinositol-
4,5-bisphosphate (PtdIns(4,5)P2) is hydrolyzed to generate the secondary messenger Ins-
(1,4,5)P3 in response to several hormonal stimuli resulting in the release of calcium from
the endoplasmic reticulum [60]. Further work demonstrated a related second messenger,
Ins(1,3,4,5)P4, increases the sensitivity of cells towards Ins(1,4,5)P3 in a cooperative man-
ner and results in a longer-lasting signal [18, 61, 62]. Additional less-phosphorylated IPs
have characterized roles in cellular processes such as chloride secretion, iron accumulation,
chromatin remodeling, gene expression, and hormone signaling [49, 53, 63–66]
1.2.4 Phosphoinositides
In 1930, the presence of inositol within the lipid fraction of bacteria was discovered and
the presence of inositol containing phospholipids (phosphatidylinositol: PtdIns) has been
identified in many archaea, all eukaryotes and a few bacteria [2, 67, 68]. The phosphory-
lated forms of PtdIns are collectively know as phosphoinositides (PIs) with phosphatidyl-
inositol-4,5-bisphosphate (PtdIns(4,5)P2) being the first identified PI [69–71]. In 1953,
the “phospholipid effect” was first observed when external stimulation effected changes in
the PI turnover rates [72–75]. PIs typically make up less than 15% of the total cell phos-
pholipids with asymmetric distributions within membranes [72, 76]. Roles of PIs include
acting as precursors for second messengers, membrane anchoring sites for proteins, or-
ganelle identification and targeting, exocytosis, endocytosis, signal transduction pathways,
regulation of integral plasma membrane proteins, and plasma membrane-cytoskeleton in-
teractions [46, 72, 74, 77–84].
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1.2.5 myo-inositol pyrophosphate
myo-inositol pyrophosphates (PP-InsPs) contain a diphosphoryl group (pyrophosphate;
PP) attached to the myo-inositol ring. After their initial identification in 1993, PP-InsPs
have been found in all eukaryotes tested to date [56, 57, 85]. PP-InsPs are produced by
the phosphorylation of InsP6 and Ins(1,3,4,5,6)P5, creating high-energy bonds similar to
adenosine diphosphate (ADP) and adenosine triphosphate (ATP) [57, 86]. PP-InsPs are
able to phosphorylate specific proteins in an ATP and enzyme independent manner, and
participate in processes such as endocytosis, exocytosis, ribosome biogenesis, chemotaxis,
apoptosis, regulation of telomere length, response to environmental stresses, and chromatin
remodeling [53, 87–95].
1.3 myo-inositol phosphatases
The discovery of InsP6 in 1907 led to the identification of myo-inositol phosphatases
(IPases; also known as phytases) which hydrolyzed InsP6 into inorganic phosphate and
a less-phosphorylated IP or myo-inositol [10, 11, 96]. Since their discovery, IPases have
been identified in all eukaryotic organisms as components of biosynthetic and regulatory
pathways [97, 98]. In a variety of microorganisms, IPases serve as phosphate scavenging
proteins and some have been implicated in pathogenesis [2, 32, 99, 100].
Interest in IPases initially arose within the field of nutrition with the observation that
cereals are rachitogenic for puppies due to the chelating properties of InsP6 impairing
calcium absorption [101–103]. To increase the nutritional value of cereals, research was
aimed to identify conditions that led to InsP6 hydrolysis [103]. By 1936, researchers under-
stood some ingested InsP6 was broken down in mammal intestines with three possible IPase
sources considered: digestive secretions, the food, or intestinal microorganisms [103–106].
It was ruled out that IPases were produced by digestive secretions and demonstrated that
feed containing high levels of endogenous IPase activity promoted weight gain in live-
stock [104, 107–112]. Subsequent studies indicated the nutrient availability of InsP6 was
6
1.3. MYO-INOSITOL PHOSPHATASES
better for ruminants than non-ruminants leading to the discovery in 1956 that ruminant
microorganisms were responsible for the majority of InsP6 breakdown [113]. These ob-
servations made it evident that the IPase activity was primarily the actions of the intestinal
flora within ruminants [103, 104, 111]. It is now common practice to supplement livestock
feed with microbial IPases as it increases the nutritional value of cereal crops, especially in
the case of non-ruminants [103, 114]. It also reduces the demand for inorganic phosphorus
supplements and decreases phosphate pollution by reducing the amount of InsP6 excreted
into the environment [114–117]. IPase supplements are also found in human foods where
they enhance mineral availability and lower the risk of mineral deficiencies caused by the
chelating effects of InsP6 [118–120].
In addition to their use in the feed industry, IPases have been utilized in the biosynthesis
of various less-phosphorylated IPs [114]. The importance of IPs within biological systems
is becoming more apparent and to better understand their various roles a reliable source is
needed. Chemical synthesis is difficult due to the large number of stereoisomers, whereas
an enzymatic synthesis has the advantage of high stereospecificity and mild reaction con-
ditions [22, 121]. IPases have been successfully used to produce the less-phosphorylated
IPs by incubation with InsP6 [120–122]. To date the enzymatic approach has had limited
application due to difficulties purifying large quantities of pure products [96]. A greater
understanding of IPases will provide a means for improving the process.
To date, the majority of IPase research has been directed at improved livestock and
human feed supplements resulting in extensive studies of microbial IPases [114]. Four
classes of microbial IPases have been described based on primary sequence and structural
similarities. These four enzyme classes are purple acid phosphatases (PAPs), β-propeller
phytases (BPPs), histidine acid phosphatases (HAPs), and protein tyrosine phosphatase-like
myo-inositol phosphatases (PTPLPs). Each IPase class is capable of removing multiple
phosphoryl groups from InsP6 and display varying degrees of specificity. Based on the
initial position of hydrolysis, the Enzyme Nomenclature Committee of the International
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Union of Biochemistry recognizes three types of phytase namely, 3-phytases (EC 3.1.3.8),
4-phytases (3.1.3.26), and 5-phytases (EC 3.1.3.72).
1.3.1 Purple acid phosphatases
In 1973, the first purple acid phosphatase (PAP) was identified in pig allantoic fluid
(Uteroferrin) and GmPhy from germinating soybeans was the first PAP that exhibited IPase
activity [123–126]. Since then, few PAPs demonstrated IPase activity and they appear to
represent a small subset of the PAPs class [126–129]. PAPs consist of homodimers with
each monomer composed of an N-terminal antiparallel β-sandwich and a larger C-terminal
α+β domain (Figure 1.3) [130]. Each monomer contributes two α-helices to the dimer
interface. PAPs have five signature sequences (DXG, GDXXY, GNH(D/E), VXXH, and
GHXH; bold letters indicate metal ligating residues) that are involved in coordinating the
Fe(III)-M(II) centre, where M can be Fe, Mn or Zn [126, 129–132]. The catalytic mecha-
nism involves the direct attack of the scissile phosphate by an activated water coordinated
by the metal centre [130]. The optimal pH range for PAPs that function as IPases is between
4.5 and 6 [126,129].
1.3.2 β-propeller phytases
Originally isolated from Bacillus species in 1998, the β-propeller phytases (BPPs)
have since been shown to be widely distributed among bacteria [133–136]. BPPs adopt
a β-propeller fold with a solvent-accessible central channel that binds calcium ions (Fig-
ure 1.4) [137, 138]. The bound calcium increases the stability of the protein and is re-
quired for catalytic activity as it provides a favourable electrostatic environment that per-
mits substrate binding [139]. The substrate-binding site is located at the top of the β-
propeller and consists of several charged resides to facilitate calcium and InsP6 binding
[138]. The crystallographic structure of Bacillus subtilis in complex with the inhibitor myo-
inositol-1,2,3,4,5,6-hexakissulfate (MIHS) and the hydrolysis data indicate the enzyme is
a 4-phytase and that there are no large-scale conformational changes upon substrate bind-
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Figure 1.3: Structure of the purple acid phosphatase (PAP) homodimer from Phaseolus vul-
garis (PDB 1KBP). The iron and zinc ions of the metal centre are shown as brown and green
spheres, respectively. The protein is oriented so the N-terminal antiparallel β-sandwich is
at the bottom of the homodimer and the C-terminal α+β domain is at the top. The proteins
are shown as ribbons with the β-sheets in dark and light blue, α-helices are red and orange,
and the loops are in grey.
ing [137–139]. BPP contain two phosphoryl-binding sites where one is the clevage site and
the other binds an adjacent phosphoryl group [140,141]. Both phosphoryl-binding sites ap-
pear to need to be filled for successful hydrolysis explaining why BPPs only remove three
phosphoryl groups from InsP6 [140,141]. The optimal pH range for the BPPs is between 7
and 8 due to the protonation state of the calcium-binding residues [133,134,137].
1.3.3 Histidine acid phosphatases
In 1911, the first and most extensively studied histidine acid phosphatase (HAP) was
identified in Aspergillus niger and the crystallographic structure determined in 1997 [142,
143]. The HAP class of IPases contain two domains: an α/β-domain from the acid phos-
phatase family and an α-domain unique to IPase HAPs with the substrate-binding pocket
located at the domain interface (Figure 1.5) [143, 144]. The greatest conservation among
HAPs is within the α/β-domain that contains the active-site signature sequence (RH(G/N)-
XRXP) for binding and catalysis and the downstream HD sequence involved in product
binding and release [143,145]. The α-domain is involved in conferring substrate specificity
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Figure 1.4: Structure of the β-propeller phytase (BPP) from Bacillus subtilis in com-
plex with myo-inositol-1,2,3,4,5,6-hexakissulfate (MIHS) (PDB 3AMR). Calcium ions are
shown as grey spheres and MIHS as cylinders with carbon in grey, sulfur in yellow and
oxygen in red. The protein is shown as a ribbon with β-sheets in blue, α-helices in red and
the loops in grey.
by contributing multiple interactions with phosphoryl groups not adjacent to the scissile
phosphate that stabilizes the orientation of InsP6 within the active site [144, 146, 147]. The
conformation of the single axial phosphoryl group dictates the InsP6 specificity of both the
3- and 4-phytases [144, 145]. In the case of the 3-phytases, binding of the C3-phosphoryl
group for hydrolysis is due to the steric interactions restricting the axial C2-phosphoryl
group to a specific location adjacent to the scissile phosphoryl [144,145]. In the case of the
4-phytases, steric restraints limit the phosphoryl groups adjacent to the scissile phosphoryl
group to be in the equatorial conformation placing the axial group away from the binding
site [148]. HAPs continue to dephosphorylate the products of the hydrolyzed InsP6 to pro-
duce InsP [145, 148]. HAPs utilize a two-step catalytic mechanism where the first step is
the formation of the phospho-histidine intermediate between the scissile phosphate and the
histidine in the RH(G/N)XRXP signature sequence [114, 149–152]. In the second step of
the reaction the aspartic acid of the HD motif protonates the bridging oxygen of the leaving
group as the phospho-histidine intermediate is hydrolyzed by an incoming water molecule,
releasing the histidine for subsequent reactions. The optimal pH of the IPase HAPs are 2.5
or the within range of 4.5 to 6 [131,153].
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Figure 1.5: Structure of the histidine acid phosphatase (HAP) from Aspergillus niger
(PhyA) in complex with myo-inositol-1,2,3,4,5,6-hexakissulfate (MIHS) (PDB 3K4Q). The
ligand is bound in the substrate-binding pocket located at the domain interface with the
α-domain at the top and the α/β-domain at the bottom. MIHS is shown as cylinders with
carbon in grey, sulfur in yellow and oxygen in red. The protein is shown as a ribbon with
β-sheets in blue, α-helices in red and the loops in grey.
1.3.4 Protein tyrosine phosphatase-like myo-inositol phosphatases
In 1998, investigation of the rumen organisms with the highest InsP6 activity resulted
in the identification of the first protein tyrosine phosphatase-like myo-inositol phosphatases
(PTPLPs) [154–156]. Since their initial identification in Selenomonas ruminantium and
Mitsuokella multacida, PTPLPs have been found in a range of bacterial organisms and
have been shown to participate in phosphate scavenging, reversing iron-restricted growth
inhibition, and pathogenesis [156–161]. The PTPLPs of S. ruminantium (PhyAsr) and
M. multacida (PhyAmm) are associated with the outer membrane which is also the case
for the PTPLP of the predatory bacterium Bdellovibrio bacteriovorus (PhyAbb), while the
PTPLPs of pathogenic bacteria are injected into host cells [155, 157, 159–161]. PTPLPs
consist of two domains: the large catalytic PTP domain and a smaller phytase-specific
(Phy) domain (Figure 1.6) [162]. The PTP domain is an α-β-α sandwich with two signa-
ture sequences that are responsible for catalysis [162–165]. The phosphate-binding loop
(P-looop; CXXGXGR(S/T)) provides the nucleophilic cysteine and binds the scissile phos-
phoryl group, while the general-acid loop (GA-loop; HD) provides an acidic aspartate.
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The PTP domain almost exclusively contributes contacts with the IP substrates through the
P-loop and GA-loop [166]. The Phy domain is an antiparallel α-β sandwich which has
been identified as contributing to the specificity of the PTPLPs [162, 166]. The PTPLP
active site is located at the domain interface between the domains with the P-loop forming
the base of the active site coordinating the scissile phosphoryl group and the GA-loop at
the back [162,166].
Figure 1.6: Structure of the protein tyrosine phosphatase-like myo-inositol phosphatase
(PTPLP) from S. ruminantium (PhyAsr) in complex with InsP6 (PDB 3MMJ). The protein
is orientated so that the α-β-α sandwich PTP domain is at the bottom and the antiparallel
α-β sandwich Phy domain is located at the top right with InsP6 bound at the domain inter-
face. InsP6 is shown as cylinders with carbon in grey, phosphorus in orange and oxygen in
red. The protein is shown as a ribbon with β-sheets in blue, α-helices in red and the loops
in grey.
PTPLPs catalyze the hydrolysis of phosphodiester bonds following a two-step PTP-
like mechanism [162–165]. In the first step, the invariant P-loop cysteine thiolate nucle-
ophilically attacks the scissile phosphate. This generates a phospho-cysteine intermediate
that is subsequently hydrolyzed. The aspartate of the GA-loop serves as a general base
in step two, generating a hydroxyl by abstracting a proton from a water molecule that at-
tacks the phospho-cysteine intermediate, releasing an inorganic phosphate and regenerat-
ing the enzyme [164, 167]. Isosteric site-directed mutations of the nucleophile cysteine
to serine and the aspartate general acid to asparagine result in complete and partial inac-
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tivation of PTPLPs, respectively [165]. This is consistent with the above mechanism and
similar studies examining the catalytic mechanism of PTPs. Further, the crystallographic
structure of PhyAsrC252A in complex with inorganic phosphate and Ins(1,2,3,5,6)P5 (PDB
3MOZ) closely resembles the structure of the PTP1B phospho-enzyme intermediate (PDB
1A5Y) [166]. In this work, the smaller alanine side chain allows the inorganic phosphate
to bind deeper within the P-loop of the PhyAsrC252A complex structure, where it occupies
a position that is structurally equivalent to the phosphoryl group of the PTP1B phospho-
enzyme intermediate.
The active sites of PTPLPs have an overall positive electrostatic surface potential to
offset the negative charge of the IP substrates [162]. With the predominant electrostatic
interactions between the protein and substrates, the activity of PTPLPs vary strongly with
ionic strength and have pH optima of 4.5 to 6 [162, 165, 168, 169]. The noted exception
is the PTPLP from Xanthomonas campestris pv. vesicatoria (XopH) with a pH optimum
of 7 that is optimized for activity within host cells [161]. PTPLPs classified as 1-, 3-,
and 5-phytases have been identified [157, 158, 161, 165, 170]. With the noted exception
of XopH which stops at producing Ins(2,3,4,5,6)P5 from InsP6, each PTPLP hydrolyzed
InsP6 to Ins(2)P through different dephosphorylation pathways [157,158,161,165,170]. In
each case, PTPLPs have been shown to have activity for IPs other than InsP6 with varying
specificities [157–161,165,169,170].
To facilitate the discussion of substrate conformation within the active site, the six
phosphoryl-binding sites identified in the structure of PhyAsrC252S in complex with InsP6
complex are referred to as the Ps, Pa, Pb, Pa′ , and Pb′ sites (Figure 1.7) [166]. The scissile
phosphoryl group binds the Ps cite formed by P-loop and GA-loops which orients the phos-
phoryl group for hydrolysis and is conserved in all PTPLPs. The remaining sites are more
variable in terms of number of contacts and steric restrictions but have been identified in
PhyAsr, PhyAmm and PhyAbb [160,166,169]. In PhyAsr, the Pa′ site forms multiple direct
contacts with the only axial phosphoryl group of InsP6 suggesting strong interactions, and
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is likely responsible for the strict C3-phosphoryl group specificity of the enzyme as it can
only accommodate the axial phosphoryl or a hydroxyl group [165]. The Pa site forms mul-
tiple direct contacts with the substrate also suggesting a strong interaction, while the Pb site
makes multiple solvent-mediated contacts suggesting a weaker interaction. In the case of
the Pb′ and Pc sites, they have relatively few contacts which are typically mediated by sol-
vent suggesting a smaller contribution to InsP6 binding. Taken together, this suggests that
the Pa′ , Pa and to a lesser extent the Pb sites are responsible for the bulk of the favourable
interactions between the protein and non-scissile phosphoryl groups of PhyAsr.
Figure 1.7: Schematic representation of InsP6 bound to the active site of PhyAsr (PDB
3MMJ). The grey spheres represent the phosphoryl group within the binding sites labelled
Ps (scissile phosphate), Pa, Pa′ , Pb, Pb′ , and Pc for reference. The C3-phosphoryl group
is bound to the Ps site with the axial C2-phosphoryl group bound to the Pa′ site. InsP6
is shown as cylinders with carbon in grey, phosphorus in orange and oxygen in red. The
protein is shown as a ribbon with β-sheets in blue, α-helices in red and the loops in grey.
PhyAmm is a tandem repeat that contains two PTPLP folds with distinct activities to-
wards IPs [169]. The C-terminal repeat closely resembles PhyAsr with nearly identical
residues available to interact with the substrates. The N-terminal repeat has residue sub-
stitutions, insertions and deletions that restrict the space available for IP binding compared
to both the C-terminal repeat and PhyAsr. Through activity studies it has been demon-
strated that the size of the active site has an influence on the substrate preference, with the
C-terminal repeat having a preference for InsP6 and InsP5 and the N-terminal repeat hav-
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ing almost no activity towards these larger substrates while retaining activity towards the
InsP4 and InsP3 substrates [169]. Mutagenesis studies suggest that the difference in elec-
trostatic surface potential, mutations in the vicinity of the active sites and steric constraints
are involved in the altered substrate specificity of the N-terminal repeat of PhyAmm [169].
1.4 Objective
In order to understand the substrate specificity of protein tyrosine phosphatase-likemyo-
inositol phosphatases (PTPLPs), I have determined the structure the PTPLPs from Mit-
suokella multacida (PhyAmm) and Selenomonas ruminantium (PhyAsr) in complex with
multiple myo-inositol phosphates (IPs). In Chapter 2, I present the structures of PhyAsr in
complex with Ins(1,3,4,5)P4 and Ins(1,4,5)P3, and PhyAmm in complex with Ins(1,3,4,5)-
P4. Based on these structures, I identify three structural features I predict contribute to
the substrate specificity of PTPLPs. I test this hypothesis in Chapter 3 by presenting the
structure of PhyAmm in complex with Ins(1,2,4,5,6)P5. Supporting the structural studies,
I present InsP6 hydrolysis data of the two repeats of PhyAmm as well as the PTPLP from
Bdellovibrio bacteriovorus (PhyAbb). The structure and biochemical data support the hy-
pothesis that the three structural features I have identified contribute to the specificity of
these enzymes. Further, I present a novel IP specificity assay that demonstrates the two
repeats of PhyAmm have divergent activities that clearly indicate a “divide and conquer”
approach to maximize phosphoryl group removal from mixed IPs.
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Chapter 2
Bacterial PhyA protein tyrosine
phosphatase-like myo-inositol
phosphatases in complex with the
Ins(1,3,4,5)P4 and Ins(1,4,5)P3 second
messengers1
2.1 Introduction
Myo-inositol phosphates (IPs) containing between one and eight phosphoryl groups are
ubiquitous in eukaryotic species and have diverse biological activities [18]. The most abun-
dant, myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP6 or phytate), has multiple important
roles in eukaryotic cellular processes including regulating plant hormone receptors, DNA
repair, RNA processing, mRNA export, plant development, apoptosis, and pathogenic-
ity [24, 27–32, 98]. Less-abundant, less-phosphorylated IPs have also been implicated in
many important biological processes including second messenger activities [18, 19]. For
example, the role of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in calcium mobilization has been well
characterized [18,62]. Ins(1,4,5)P3 stimulates the release of calcium from the endoplasmic
reticulum resulting in further cellular responses, and Ins(1,3,4,5)P4 acts to increase sensi-
tivity and generate a longer-lasting signal. In general, highly-phosphorylated IPs (InsP6 and
1This chapter is an adapted version of the manuscript “Bacterial PhyA protein tyrosine phosphatase-like
myo-inositol phosphatases in complex with the Ins(1,3,4,5)P4 and Ins(1,4,5)P3 second messengers. 2017.
Bruder, L.M., Gruninger, R.J., Cleland, C.P., and Mosimann, S.C. J Biol Chem. 292: 17302-17311.”
L.M.B. wrote the paper and performed the work presented here, with the exception of the PhyAbb pathway
which was determined by C.P.C.
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InsP5) serve as cofactors, whereas less-phosphorylated IPs are utilized as second messen-
gers in signal transduction pathways [19]. In contrast to eukaryotic cells, IPs are typically
absent from prokaryotes [8, 171], despite the presence of enzymes specific for IPs (IPases)
in many organisms. Known microbial IPases have few characterized roles in prokary-
otes [99]. Most serve as phosphate scavenging proteins, and more recently others have
been implicated in pathogenesis [2, 32, 100].
Microbial IPases that specifically hydrolyze the C3- and C4-phosphoryl groups of InsP6
(D-myo numbering) are common, and experimental structures of both classes of enzyme are
available [145,148,166]. Structural features that determine C3-phosphoryl group specificity
of IPases (3-phytases) have been identified for two distinct enzyme families: protein tyro-
sine phosphatase-like myo-inositol phosphatase (PTPLPs) and histidine-acid phosphatases
(HAPs) [145,166]. In each of these cases, the InsP6 substrate adopts its lowest energy con-
formation, and steric interactions restrict the only axial phosphoryl group (C2) to a specific
location adjacent to the scissile phosphoryl group [144,145,166].
PTPLPs and HAPs hydrolyze InsP6 to produce myo-inositol-2-monokisphosphate (Ins-
(2)P) and inorganic phosphate after prolonged incubation [148,157,158,165,170]. Charac-
terized PTPLPs have been shown to hydrolyze InsP6 to Ins(2)P via different dephosphory-
lation pathways [157,158,165,170]. An example is PhyA from Selenomonas ruminantium
(PhyAsr), which first removes the C3-phosphoryl group (P3) followed (in order) by P1, P6,
P5, and P4 [165]. PTPLPs such as PhyA from Mitsuokella multacida (PhyAmm) and Le-
gionella pneumophila (LppA) have demonstrated activity towards the Ins(1,4,5)P3 second
messenger [159, 169]. It is likely these enzymes can also hydrolyze additional IP second
messengers and that this activity is shared by other PTPLPs.
Here we have presented the first structures of bacterial PTPLPs in complex with eu-
karyotic IP second messengers, representing crystallographic evidence that PTPLPs bind
and hydrolyze these compounds. These IPs bind in a different conformation than InsP6
while utilizing a subset of the previously determined phosphoryl-binding sites [166]. Fur-
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ther, we have identified several variable loops adjacent to the active site that influence their
dephosphorylation pathways. Consequently, this work both refines and extends previous
studies aimed at understanding the function and specificity of these enzymes and likely
applies to other IPase families.
2.2 Experimental procedures
2.2.1 Expression and purification
The phyA genes of the S. ruminantium (phyAsrC252S),M. multacida (phyAmmC250S/-
C548S), and Bdellovibrio bacteriovorus HD100 (PhyAbb; previously Bd1204), minus the
putative signal peptide, were previously cloned into the NdeI site of the pET28bKan expres-
sion vector (EMD Biosciences) [160, 165, 169]. The PhyAsrC252S and PhyAmmC250S-
/C548S proteins are catalytically inactive as a result of the cysteine to serine mutation (an
isosteric subsitution). All contained an N-terminal His6 tag and were produced and puri-
fied as described previously [160, 165, 166, 169]. PhyAsrC252S was dialyzed into 20 mM
ammonium bicarbonate (pH 8.0) and lyophilized, while PhyAmmC252S/C548S was dia-
lyzed into 100 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM β-mercaptoethanol (BME),
and 0.1 mM ethylenediaminetetraacetic acid (EDTA; pH 8.0) followed by the addition of
glycerol to 20% v/v, and PhyAbb was dialyzed into 50 mM Na acetate (pH 5.0) 300 mM
NaCl, 5 mM BME, and 0.1 mM EDTA (pH 8.0). The protein was used immediately or
flash-frozen and stored at 193 K.
2.2.2 Crystallization
Crystallization experiments were conducted at room temperature using sitting-drop vap-
our diffusion with drop ratios of 2 µL protein solution to 2 µL reservoir solution. PhyAsr-
C252S protein solutions were prepared at 20 mg/mL, and crystals were grown as de-
scribed previously [168]. PhyAmmC250S/C548S protein solutions were concentrated to
4.5 mg/mL using a Millipore Ultracel 10-kDa Centrifugal Filter, and crystals were grown
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in 10% w/v polyethylene glycol (PEG) 8000, 100 mM Tris-HCl (pH 8.0), 1 mM BME,
4% v/v ethylene glycol, and 20% v/v glycerol. Following a 24-h equilibration, the reser-
voir solution was supplemented with 100 µL of glycerol. After 30 days PhyAsrC252S
grew rod-like crystals with approximate dimensions of 30 × 30 × 100 µm, and after
10 days PhyAmmC250S/C548S grew rod-like crystals with approximate dimensions of
100 × 100 × 500 µm. In each case, crystals were soaked in mother liquor supplemented
with 10 mM Ins(1,3,4,5)P4 (15 minutes; Echelon Bioscience) or 10 mM Ins(1,4,5)P3 (15 min-
utes; Sigma-Aldrich). Following the introduction of ligand, PhyAsrC252S crystals were
transferred to mother liquor containing 22 to 25% v/v glycerol (cryoprotectant) and flash-
frozen in liquid nitrogen. PhyAmmC250S/C548S crystals were flash-frozen directly fol-
lowing the introduction of ligand.
2.2.3 Data collection and image processing
Diffraction data (λ = 0.97934 A˚) was collected from frozen crystals (100 K) using a
Rayonix MX300 CCD detector at beamline 08ID-1 located at the Canadian Light Source
(CLS; Saskatoon, SK, Canada). The space group and unit cell parameters of the PhyAsr-
C252S crystals in complex with ligand are equivalent to those of the PhyAsrC252S·InsP6
structure (PDB 3MMJ), whereas the PhyAmmC250S/C548S·Ins(1,3,4,5)P4 crystal has a
novel P1 unit cell. All diffraction image data were processed interactively with MOSFLM
prior to scaling and merging within AIMLESS of the CCP4 program suite, version 6.3.0
[172–175]. Data collection statistics are shown in Table 2.1.
2.2.4 Structure refinement and model validation
Phases derived from the PhyAsrC252S·InsP6 structure (PDB 3MMJ) and wild-type
PhyAmm (PDB 3F41) were used to solve the structures by molecular replacement (MOL-
REP). The refined structures have continuous electron density for main-chain atoms of
amino acids 33 to 346 of PhyAsrC252S and 46 to 636 of PhyAmmC250S/C548S, with
the remaining residues located at the termini assumed to be disordered. This includes the
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Table 2.1: Data collection and refinement statistics for the PhyAsrC252S·Ins(1,3,4,5)P4,
PhyAsrC252S·Ins(1,4,5)P3, and PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structures.
1
PhyAsrC252S PhyAsrC252S PhyAmmC250S/C548S
Ins(1,3,4,5)P4 Ins(1,4,5)P3 Ins(1,3,4,5)P4
PDB code 4WTY 4WU2 4WU3
Data collection
Space group P21 P21 P1
a, b, c (A˚) 45.8, 138.2, 80.6 46.0, 137.7, 80.0 73.9, 86.7, 124.2
α, β, γ (◦) 90.0, 102.3, 90.0 90.0, 102.4, 90.0 107.3, 91.7, 90.0
Wavelength (A˚) 0.97934 0.97934 0.97934
Resolution (A˚) 43.0 - 2.10 44.9 - 2.15 44.5 - 2.20
(2.16 - 2.10) (2.21 - 2.15) (2.24 - 2.20)
Observed reflections 214 850 175 251 323 812
Unique reflections 57 016 52 695 146 418
Completeness (%) 100 (100) 99.9 (100) 98.1 (96.6)
Redundancy 3.8 (3.7) 3.3 (3.3) 2.2 (2.2)
Rmerge (%) 13.5 (48.1) 12.8 (52.3) 8.0 (16.0)
I / σI 6.2 (2.3) 6.1 (1.9) 7.2 (4.3)
Refinement Statistics
No. reflections work set 55 187 50 541 144 299
No. reflections test set 1 797 2 154 2 118
Rwork / Rfree (%) 15.7 / 17.5 19.7 / 21.9 19.0 / 21.3
Asymmetric unit Dimer Dimer Dimer of Dimers
Protein atoms 5 057 5 096 19 188
Solvent atoms 663 484 2 262
Ligand atoms 93 83 270
Wilson B (A˚2) 27.51 31.04 19.52
Average B protein (A˚2) 26.2 30.5 18.4
Average B solvent (A˚2) 35.3 35.3 27.4
Average B ligand (A˚2) 42.4 35.3 39.4
RMSD Bonds (A˚) 0.005 0.008 0.007
RMSD Angle (◦) 1.067 1.153 1.106
Ramachandran distribution
Preferred (%) 97.04 95.9 96.28
Allowed (%) 2.46 3.44 2.69
Outliers (%) 0.49 0.66 1.03
1 values in parenthesis are for the highest resolution shell
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N-terminal histidine tag of both proteins, residues 28 to 32 of PhyAsrC252S and residues
31 to 45 of PhyAmmC250S/C548S. Refinement was performed using REFMAC, version
5.7, within the CCP4 program suite, while interactive fitting of the models to the electron
density were performed in COOT, version 0.6.2, [173, 176]. PROCHECK and structure
validation tools with COOT were used throughout refinement to assess the stereochemistry
of the model [177]. Unless indicated otherwise, figures were prepared with CCP4mg, ver-
sion 2.10.8 [178]. Key data processing and refinement statistics for each PhyAsrC252S and
PhyAmmC250S/C548S complex structures are presented in Table 2.1.
2.2.5 Structure analysis
These and previously determined structures were compared by least squares (LSQ) su-
perposition using LSQKAB from the CCP4 program suite [173]. The main-chain atoms of
residues 35 to 346 of PhyAsrC252S, and 47 to 342 and 343 to 636 for the N- and C-terminal
repeats of PhyAmmC250S/C548S, respectively, were used in overall fold comparisons.
Active-site comparisons were made using residues 56 to 58, 152 to 154, 189 to 190, 221
to 226, 249 to 262, 304 to 309, and 311 to 313 of PhyAsrC252S, and 448 to 450, 484 to
486, 517 to 522, 545 to 558, 584 to 586, and 599 to 605 of the PhyAmmC250S/C548S
C-terminal repeat. Differences in the relative position of the myo-inositol ring of bound
ligands of PhyAsrC252S were calculated using the superposed structure coordinates and
GEOMCALC in the CCP4 program suite [173, 176].
2.2.6 Identification of hydrolysis products
Hydrolysis of 5 mM InsP6 (Sigma-Aldrich) was carried out at room temperature in
the presence of 10 nM wild type PhyAsr or PhyAmm (50 mM sodium acetate pH 5.0,
200 mM NaCl, 1 mM BME, 0.1 mM EDTA). In the case of PhyAbb, 100 nM protein
and 10 mM InsP6 were used. Aliquots of 200 µL were taken, heat-denatured at 95
◦C
for 2 min, and subjected to high performance ion chromatography (HPIC; Waters 1525
Binary HPIC Pump; Milford, MA) utilizing a CarboPac PA-100 (4 x 240 mm) analytical
21
2.3. RESULTS
column (Dionex; Sunnyvale, CA) [179] at room temperature using a post-column reactor
flow rate of 0.2 mL/min. Identification of hydrolysis products utilized a standard hydrolysis
chromatogram (Appendix A experimental procedures).
2.3 Results
2.3.1 Active sites of PTPLPs are pre-formed
The overall fold of PTPLPs are composed of a catalytic α-β-α sandwich PTP domain
and an antiparallel α-β sandwich Phy domain. The active site includes the general acid loop
(GA-loop) and phosphate-binding loop (P-loop) from the catalytic PTP domain as well as
residues from both domains that participate in substrate binding [166]. The fold and active
site of PhyAsr is shown in Figure 2.1 A. Least squares (LSQ) superpositions of PhyAsr
crystal structures in the presence and absence of ligand yield root-mean-square deviations
(RMSDs) of approximately 0.2 A˚ (over 1248 main-chain atoms), clearly demonstrating
there are no large-scale main-chain conformational changes associated with ligand binding
(Appendix Table A.1) [165, 166]. The same is true within the active site, as the main- and
side-chain conformation of the residues alone or in complex with InsP6, Ins(1,3,4,5)P4 or
Ins(1,4,5)P3 are essentially identical (Appendix Table A.2).
The PhyAmm monomer is an example of a tandemly repeated IPase that contains
two copies of the catalytic PTP and Phy domains (Figure 2.1 B). Although the N- and
C-terminal repeats of PhyAmm have different IP substrate specificities, they are both ac-
tive towards the Ins(1,4,5)P3 second messenger [169]. Presented here is the complex
structure of PhyAmmC252S/C548S with Ins(1,3,4,5)P4, a related second messenger. The
PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure was solved in a different space group (P1)
than PhyAmm without ligand (P21). Between the two structures, the individual repeats of
PhyAmm are nearly identical as judged by LSQ superpositions (Appendix Table A.3) [169].
Small movements in the linker region between repeats subtly alters the relative orientation
of the tandem repeats and account for the bulk of the observed differences between the
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Figure 2.1: Ribbon diagrams of the overall fold of PhyAsrC252S (grey) and PhyAmm-
C250S/C548S (brown/blue) in complex with Ins(1,3,4,5)P4. A, PhyAsrC252 is oriented so
the Ins(1,3,4,5)P4 ring and phosphoryl groups are clearly visible, with the C1-phosphoryl
group bound to the phosphate-binding loop (P-loop; yellow). B, the individual N-terminal
(brown) and C-terminal (blue) repeats of PhyAmm are shown in the same orientation as A.
C, PhyAmm oriented to view the tandem repeats and linker resulting in the Ins(1,3,4,5)P4
ligand viewed from the top with the P-loop below the ligand. The ligand atoms are shown
as sticks with carbon shown in grey, oxygen in red and phosphorus in orange. The variable
loops are shown in green. These include the extended loops prior to the penultimate helix,
the α-turn (N-terminal repeat) and β-hairpin turns (PhyAsr and C-terminal repeat), and
the extended Ω-loops. The P-loop (yellow) and the general-acid loop (GA-loop; cyan)
contribute catalytic residues. Mutation of the cysteine nucleophile to the isosteric serine
prevents thiolate formation and renders the enzyme inactive.
individual monomers and dimers. As reported previously, the dimer interface of PhyAmm
is almost exclusively formed between the N-terminal repeats, and these interactions are an
extensive network of hydrogen bonds, salt bridges, and van der Waals contacts [169]. As
seen with PhyAsr, the C-terminal active site of PhyAmmC250S/C548S is virtually iden-
tical in the presence or absence of Ins(1,3,4,5)P4 (Appendix Table A.4). Taken together,
the structures of both PhyAsr and PhyAmm support previous suggestions that the PTPLP
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family of enzymes have pre-formed active sites [166].
2.3.2 Alternative binding modes of IPs
The electron density for bound ligand is clearly visible in initial 2mFo – DFc (1.5 σ)
and mFo – DFc (3.5 σ) maps of each PhyAsrC252S structure. Refined electron density
(2mFo – DFc) for the Ins(1,3,4,5)P4 and Ins(1,4,5)P3 ligands at 1 σ are shown in Figure 2.2
A and B. Obvious electron density for the axial C2-hydroxyls and each phosphoryl group
clearly identify the conformation of each ligand bound within the active site. Interestingly,
PhyAsrC252S binds Ins(1,4,5)P3 in a position identical to that of the Ins(1,3,4,5)P4 less one
phosphate (Figure 2.3). The modeled IPs adopt the lowest-energy chair conformation with
five equatorial hydroxyl/phosphoryl groups and an axial C2-hydroxyl. The C1-phosphoryl
groups of the ligands are positioned for hydrolysis in the Ps phosphoryl-binding site by
forming extensive interactions with the P-loop (Figure 2.3; Table 2.2) [162, 166]. The
P-loop (residues 252 to 259), GA-loop (residues 222 to 225), and Lys-312 are the only
interactions that originate from the catalytic PTP domain. The remaining contacts are me-
diated by residue side chains derived from the Phy domain (residue ranges 51 to 59 and
136 to 203) and the Phy-specific extension of the penultimate helix (residues 291 to 307).
The less-phosphorylated IPs utilize a subset of the phosphoryl-binding sites identified pre-
viously in the PhyAsrC252S·InsP6 structure [166].
The myo-inositol rings of the less-phosphorylated IP complexes have different relative
orientations within the active site when compared with the PhyAsrC252S·InsP6 structure.
In particular, the myo-inositol rings are rotated by 180◦, resulting in the opposite face con-
tacting the enzyme. For the C1-phosphoryl group to maintain contact with the P-loop, the
rotated myo-inositol rings tilt toward the GA-loop (Figure 2.4). Overall, the IPs shift by
more than 1.2 A˚ (centre of mass to centre of mass; Appendix Table A.5) and fill the space
occupied by ordered solvent in the InsP6 complex structure.
The N- and C-terminal active sites of PhyAmmC250S/C548S are non-equivalent and
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Figure 2.2: Clear electron density for the phosphoryl groups and C2-hydroxyl allow for
an unambiguous fit of the ligands and places the C1-phosphoryl group (P1) above the cys-
teine to serine mutations at position 252 (PhyAsr) and 548 (PhyAmm). The refined 2mFo
– DFc electron density, contoured at 1σ (blue mesh) for PhyAsrC252S in complex with
Ins(1,3,4,5)P4 (A) and Ins(1,4,5)P3 (B) and for the PhyAmmC252S/C548S C-terminal re-
peat in complex with Ins(1,3,4,5)P4 (C). Ligand and protein are shown as sticks with oxy-
gen in red, nitrogen in blue, phosphorus in orange, and carbon in grey.
have different substrate specificities [169]. The C-terminal active site of PhyAmm is highly
active toward InsP6 and 12 of the 14 residues contacting the ligand are conserved when
compared with PhyAsr (Table 2.2). Not unexpectedly, Ins(1,3,4,5)P4 binding within the
PhyAmmC250S/C548S C-terminal active site is nearly identical to that observed in the
PhyAsrC252S·Ins(1,3,4,5)P4 structure. In contrast, the N-terminal active site of PhyAmm
does not bind ligand in a catalytically competent manner. Instead, an inorganic phos-
phate is bound by the catalytic P-loop, and a partially occupied (0.6) Ins(1,3,4,5)P4 is
bound at a novel site more than 8 A˚ (phosphorus to phosphorus) from the inorganic phos-
phate (Figure 2.3 C). The N-terminal active site has residue substitutions as well as a two-
residue insertion. The insertion is in the Phy-specific domain and generates a larger α-turn
(residues 182 to 188) that extends into the active site. The equivalent region of PhyAsr
and the C-terminal repeat of PhyAmm have smaller β-hairpin turns. The mutations in the
N-terminal repeat of PhyAmm reduce the positive electrostatic surface potential and intro-
duce additional steric limitations.
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Figure 2.3: PhyAsrC252S and the C-terminal repeat of PhyAmmC250S/C548S bind
the IP substrates nearly identically using a subset of the contacts identified in the
PhyAsrC252·InsP6 structure (PDB 3MMJ) [166]. The phosphoryl-binding sites are la-
beled according to the InsP6 structure (Ps, Pb, Pa′, and Pc). A, stereo view of the su-
perposition of PhyAsrC252S (grey) and the C-terminal repeat of PhyAmmC250S/C548S
(blue) in complex with Ins(1,3,4,5)P4. B, PhyAsrC252S in complex with Ins(1,4,5)P3 in
the same conformation as A less one phosphoryl group. C, the N-terminal active site does
not bind Ins(1,3,4,5)P4 in a catalytically competent manner. Instead, the ligand is over 8 A˚
(long dashed line) from the inorganic phosphate bound by the P-loop. The short dashed
lines represent distances between the phosphoryl group bound by the P-loop and the ser-
ine hydroxyl. Residues that interact with the ligands are derived from the P-loop (yellow),
GA-loop (cyan), Phy domain, and penultimate helix. Oxygen is shown in red, nitrogen in
blue, phosphorus in orange, and carbon in grey.
2.3.3 PTPLP specificity differences
The active sites of PhyAsr and the C-terminal repeat of PhyAmm have conserved residues
that contact the ligands (Figure 2.3; Table 2.2) [169]. However, they contain significant dif-
ferences in the main-chain conformation of three loops that contribute to the active sites
of these enzymes: the extended loop prior to the penultimate helix (PhyAsr 287 to 305
and PhyAmm 583 to 600), the extended Ω-loop (PhyAsr 73 to 102 and PhyAmm 367 to
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Table 2.2: Electrostatic and hydrogen bond distances in the PhyAsrC252S·Ins(1,3,4,5)-
P4, PhyAsrC252S·Ins(1,4,5)P3 and PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structures are
highly similar. Contact distances (<3.4 A˚) between PhyA and the ligand phosphoryl (Phos)
and hydroxyl (-OH)) groups are shown. Bolded distances are main-chain interactions.
PhyAsrC252S PhyAmmC250S/C548S
Ins(1,3,4,5)P4 Ins(1,4,5)P3 Ins(1,3,4,5)P4
Residue Site
Phos/ Distance Phos/ Distance
Residue Site
Phos/ Distance
-OH (A˚) -OH (A˚) -OH (A˚)
R57 R351
3.16
Pa′ P3 2.80 Pa′ P3 2.85
3.17 2.64
D153 Pa′ D449 Pa′ P3 3.24
K189 K485
Pa′ P3
2.73
Pa′ P3 2.60 P4 2.33 3.07
Pc P4 2.96 Pc P4 3.03
D223 Pa′ P3
3.16
D519 Pa′ P3 2.67
2.81
H224 Pa
P3 2.95
H520 Pa P3 3.02P4 3.40
P5 2.51
S252 Ps P1 2.51 P1 2.27 S548 Ps P1 2.67
E253 Ps P1 3.06 P1 3.00 Q549 Ps P1 3.22
A254 Ps P1 3.17 P1 3.24 A550 Ps
G255 Ps P1 2.91 P1 2.79 G551 Ps P1 3.15
V256 Ps P1 2.69 P1 2.92 A552 Ps P1 2.90
G257 Pa O6 3.16 O6 3.08 G553 Pa
O6 3.34
P1 3.31
R258 Ps P1
2.92
P1
2.72
R554 Ps P1
2.73
3.00 2.90 3.11
2.99 2.90 2.76
K305 K600
Pc P4
2.90
Pc P4
2.52
P4 2.41
3.10
2.51 3.15
Pb P5 2.82 P5 3.02 Pb P5
2.95
2.99
Y309 Pb P5
2.82
P5 Y604 Pb P5
2.31
2.47 2.68 3.20
3.18 3.13 3.38
398), and a β-hairpin turn of the Phy-specific domain (PhyAsr 186 to 189 and PhyAmm
482 to 485) (Figure 2.5). As the observed differences in these loop conformations may
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Figure 2.4: The superposition of PhyAsrC252S in complex with InsP6 (blue; PDB 3MMJ)
and Ins(1,3,4,5)P4 (orange) demonstrates the 180
◦ rotation and tilt of the myo-inositol ring
towards the GA-loop of the less-phosphorylated IPs relative to InsP6. The P-loop, GA-loop
and Tyr-309 are shown. The myo-inositol ring and only two of the phosphoryl groups are
displayed to simplify the diagram. Despite the rotation and tilt of the myo-inositol ring,
the C1-phosphoryl group of Ins(1,3,4,5)P4 remains bound by the P-loop, and the remain-
ing phosphoryl groups are bound by equivalent residues. For example, the C5-phosphoryl
groups in these structures form similar hydrogen bonds with Tyr-309 that originates from
the opposite side of the residue.
affect substrate access to the active site, we determined the InsP6 hydrolysis pathway for
these enzymes. The time courses of the InsP6 hydrolysis products separated by high perfor-
mance ion chromatography (HPIC) clearly demonstrates that even though the enzymes are
highly specific for the C3-phosphoryl group of InsP6, they have different specificities for the
Ins(1,2,4,5,6)P5 substrate (Figure 2.6 A and B). Comparisons with standard chromatograms
demonstrate PhyAmm is specific for the C4-phosphoryl group of Ins(1,2,4,5,6)P5, whereas
PhyAsr hydrolyzes the C1-phosphoryl (Appendix Figure A.1).
To further assess the contribution of these variable loops to the substrate specificity of
PTPLPs, we examined the structure and hydrolysis pathway of PhyAbb. PhyAbb is one of
the smallest known PTPLPs and has large deletions in the the extended loop prior to the
penultimate helix, the extended Ω-loop and the Phy-specific domain (Figure 2.5) [160]. As
a result, the active site of PhyAbb is more open and accessible than in PhyAsr or PhyAmm.
Taken together, it is expected that PhyAbb has an altered pathway and would have a broader
specificity for IPs than either PhyAsr or PhyAmm, which is confirmed by the hydrolysis
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Figure 2.5: Variable loops implicated in the substrate specificity of PTPLPs.
A, stereo view of the superposition of PhyAsrC252S·Ins(1,3,4,5)P4 (blue), PhyAmm-
C250S/C548S·Ins(1,3,4,5)P4 (red) and PhyAbb (green; PDB 4NX8) as a ribbon diagram
with the ligand as sticks. The variable loops (colored segments) that influence substrate
specificity include the extended loop prior to the penultimate helix, the extended Ω-loop,
and the β-hairpin turn within the Phy-specific domain. B, the PhyAsr (blue) active site
is relatively occluded (RO) on the Pa/Pb side and relatively accessible (RA) on the Pa′/Pb′
side. C, in the case of PhyAmm (red), the relatively occluded and relatively accessible sides
are reversed. D, PhyAbb (green) has a 13 residue deletion, which removes the loop that
contains the β-hairpin turn, resulting in an accessible (RA) active site on the Pa′/Pb′ side.
Additionally, the position of the extended loop prior to the penultimate helix of PhyAbb is
similar in position to the equivalent loop of PhyAmm, and the extended Ω-loop is deleted,
leaving the Pa/Pb side more accessible (RA). As a result, PhyAbb produces four different
InsP4 products in contrast to PhyAsr and PhyAmm.
pathway (Figure 2.6 C). Though PhyAbb is also specific for the C3-phosphoryl group of
InsP6, making it a 3-phytase, PhyAbb produces four different InsP4, which includes the
PhyAsr (Ins(2,4,5,6)P4) and PhyAmm (Ins(1,2,5,6)P4) products. The much broader speci-
ficity of PhyAbb for IPs indicates that the loops that contribute to the active site influence
substrate specificity.
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Figure 2.6: HPIC chromatograms of the PhyAsr A, PhyAmm B and PhyAbb InsP6 C hy-
drolysis products demonstrating that the hydrolysis pathways diverge to produce alternative
InsP4 products. InsP6 (5 mM) was incubated with 10 nM PhyAsr and PhyAmm at room
temperature and 100 nM PhyAbb with 10 mM InsP6. Samples were taken at 0 min (blue),
20 min (orange), 30 min (red), 40 min (green), 50 min (purple) and 60 min (cyan) and
separated using a CarboPac PA-100 analytical column with a methanesulfonic acid gradi-
ent [179]. IPs were visualized using a post-column reactor with 0.1% (m/v) Fe(NO3)3 in a
2% (m/v) HClO4 solution (0.2 mL/min).
2.4 Discussion
2.4.1 myo-inositol ring movements compensate for PTPLP active-site rigidity
There are no changes in the conformation of the active site upon binding of IP ligands
to either PhyAsr or PhyAmm (Appendix Tables A.2 and A.4). The apparent rigidity of
these enzymes suggest this may be a feature of the PTPLPs, and their specificity can be un-
derstood in simple structural terms. Further, the PhyAmmC250S/C548S C-terminal active
site binds Ins(1,3,4,5)P4 using the same phosphoryl-binding sites identified in PhyAsr (Fig-
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ure 2.3 A; Table 2.2) [166]. In the PhyAsrC252S·InsP6 structure the orientation of InsP6
was such that in the Pa′ site, only a hydroxyl or an axial phosphoryl group could be accom-
modated. Consequently, the Pa′ site was identified as the primary structural determinant
giving rise to the specificity of PhyAsr for the C3-phosphoryl group of InsP6 [165, 166].
Assuming the ring orientation remains constant, the inability of the Pa′ site to accommo-
date an equatorial phosphoryl group is sufficient to explain the known hydrolysis pathway
of PhyAsr, but does not account for all minor hydrolysis products [165]. For example,
PhyAsr produces small amounts of Ins(1,2,4,6)P4 by removing the C5-phosphoryl group
from Ins(1,2,4,5,6)P5, which requires an equatorial phosphoryl group adjacent to the scis-
sile phosphoryl group to bind within the Pa′ site.
This work identifies a significant shift and a 180◦ rotation of the myo-inositol ring in
the less-phosphorylated Ins(1,3,4,5)P4 and Ins(1,4,5)P3 complex structures compared with
the PhyAsrC252S·InsP6 structure (Figure 2.4). The ring-shift and rotation allow smaller
substrates to utilize a different subset of phosphoryl binding sites. For example, in the
PhyAsrC252S·InsP6 structure and the less-phosphorylated IP complexes, hydrogen bonds
to the C5-phosphoryl group originate from opposite sides of Tyr-309 (Figure 2.4). The
myo-inositol ring shift also allows phosphoryl groups not adjacent to the scissile phospho-
ryl group to occupy the Pa′ site. Importantly, simple modeling studies based on the observed
ring-shift suggest that, provided the Pb′ site contains a hydroxyl, the Pa′ site can accommo-
date equatorial phosphoryl groups adjacent to the scissile phosphate. Alternatively, both
the Pa′ and Pb′ sites may be able to accommodate equatorial phosphoryl groups if the ring
is allowed to adopt ring orientations that are intermediate to those observed in the InsP6 and
less-phosphorylated IP complex structures. These observations are sufficient to rationalize
the formation of minor products of the PhyAsr hydrolysis pathway and suggest PTPLPs
may be able to hydrolyze a wide-range of less-phosphorylated IPs.
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2.4.2 Structural determinants of the substrate specificity of PTPLPs
PhyAsr and PhyAmm hydrolyze Ins(1,2,4,5,6)P5 to different InsP4 products despite
having the same specificity for the C3-phosphoryl group of the InsP6 and binding Ins(1,3,4,5)-
P4 nearly identically (Figures 2.3 and 2.6) [165]. The residues that contact the ligands are
conserved between PhyAsr and PhyAmm except for residue substitutions in the P-loop
(Table 2.2). In the PhyAmm C-terminal repeat, Gln-549 immediately follows the catalytic
Cys-548 (Ser-548 in our structure), whereas the equivalent residue in the PhyAsr is Glu-
253. The Gln-549 side chain of PhyAmm is directed towards the active site and may directly
or indirectly contact highly phosphorylated IPs providing an additional favourable electro-
static interaction in the Pa′ site. In contrast, both in the presence and absence of ligand,
the side chain of Glu-253 (PhyAsr) is directed away from the active site. The charge dif-
ference and the spatial orientation in the Pa′ site are capable of influencing the difference
in the activity and specificity of these enzymes but does not fully account for the pathway
divergence.
The extended loop prior to the penultimate helix, extended Ω-loop, and β-hairpin in the
Phy domain are loops around the active site that are different in PhyAsr and PhyAmm and
contribute to the divergent pathways (Figure 2.5). The main-chain conformational differ-
ences in these connecting segments result from residue substitutions, insertions/deletions,
and the distinct homodimers formed by each enzyme. The extended loop prior to the penul-
timate helix of PhyAsr located on the Pa/Pb side of the active site contain a single residue
insertion, and the C-terminal end of the loop folds into the active site of the enzyme. In
contrast, the equivalent loop in PhyAmm is pulled away from the active site and partici-
pates in a two-fold symmetric, homodimer interface. Also located on the Pa/Pb side of the
active sites are the extended Ω-loops. These loops have similar conformations, and there
is a structurally equivalent lysine (PhyAsr Lys-83 and PhyAmm Lys-379) pointing toward
the active site. However, the extended Ω-loop of PhyAmm has a two-residue insertion that
leaves the active site more accessible on the Pa/Pb side than PhyAsr. On the Pa′/Pb′ side of
32
2.4. DISCUSSION
the active site is the β-hairpin turn, which differs both in type (PhyAsr Type II; PhyAmm
Type I) and orientation between the two active sites. The conformational difference is pri-
marily a result of homodimer formation even though the turn and associated β-strands have
several residue substitutions. In particular, PhyAsr residues 191 to 193 are part of the two-
fold symmetric homodimer interface that features an intermolecular antiparallel β-sheet,
whereas the equivalent residues in PhyAmm interact with solvent. As a consequence of
these differences, the β-hairpin and following residues are pulled away from the active site
in PhyAsr to facilitate homodimer formation, whereas the equivalent residues of PhyAmm
extend into the active site on the Pa′/Pb′ side.
Taken together, the residue substitution and main-chain conformational differences indi-
cate that the PhyAsr active site is relatively occluded on the Pa/Pb side of the active site and
relatively accessible on the Pa′/Pb′ side (Figure 2.5). In the case of the PhyAmm active site,
the converse is true. This is consistent with the specificity of PhyAsr for the C1-phosphoryl
group of Ins(1,2,4,5,6)P5, as it would place the C3-hydroxyl on the relatively occluded side
of its active site. Likewise, the specificity of PhyAmm for the C4-phosphoryl group of
Ins(1,2,4,5,6)P5 would place the C3-hydroxyl on the opposite side of its active site, which
corresponds to its occluded side.
The structure and pathway of PhyAbb support the occlusion theory as an explanation
of the divergent pathways of PhyAsr and PhyAmm. PhyAbb lacks the β-hairpin in the
Phy-specific domain on the Pa′/Pb′ side of the active site, leaving it more accessible than
in either PhyAsr or PhyAmm (Figure 2.5). Further, the deletions of the extended Ω-loop,
in the extended loop prior to the penultimate helix, and of two turns of the penultimate
helix result in a more accessible Pa/Pb side of the active site. The result is a more open and
accessible active site that allows Ins(1,2,4,5,6)P5 to bind in multiple orientations and gives
rise to four distinct InsP4 ligands.
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2.4.3 Ins(1,3,4,5)P4 is not bound at the catalytic site of the PhyAmm N-terminal re-
peat
The PhyAmm N-terminal repeat shares 36% and 34% sequence identity with the C-ter-
minal repeat and PhyAsr, respectively [169]. Not surprisingly, the main-chain conforma-
tion of the N-terminal active site shares a high degree of similarity with both PhyAsr and
the C-terminal repeat of PhyAmm (0.71 and 0.28 A˚, respectively, 128 atoms). Despite
the closely similar main-chain conformations, in our structure only the C-terminal repeat
binds Ins(1,3,4,5)P4 in a catalytically competent manner. Differences between the N- and
C-terminal repeat active sites have been discussed previously [169]. At present, there is no
clear and unambiguous rationale for the lack of binding of Ins(1,3,4,5)P4 to the N-terminal
repeat P-loop. We note that Ins(1,3,4,5)P4 is not a natural substrate for this enzyme, and
the observed binding sterically prevents another Ins(1,3,4,5)P4 from binding to the P-loop.
Further, the natural InsP4 substrates, which contain a C2-phosphoryl, cannot bind in the
same manner because of steric clashes involving this axial phosphoryl group. This suggest
that what we observed was a binding site that is preferred by non-native substrates. Alterna-
tively, the structure was produced by soaking the substrate into a pre-formed crystal, which
may prevent binding if there is an induced fit associated with IP binding to the N-terminal
active site.
2.4.4 Biological implications
PhyAsr, PhyAmm and PhyAbb all function as 3-phytases yet have different specificities
for Ins(1,2,4,5,6)P5, thus producing alternative InsP4 products. In the case of PhyAsr and
PhyAmm, we were unable to predict their different specificities by identification of residues
directly interacting with the substrates, as they are essentially identical. This suggests sub-
strate specificity is influenced by structural features that do not directly interact with the
bound ligand. We identified three variable loops unique to PTPLPs that alter substrate ac-
cess to the PhyAsr and the PhyAmm C-terminal repeat active sites, which may explain their
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observed specificities. This role of the variable loops is supported by our ability to predict
and demonstrate that PhyAbb, an enzyme with large deletions in these loops, has a broad
specificity towards IP substrates.
The activity of PTPLPs towards second messengers has been demonstrated, and this
work confirms that two second messengers, Ins(1,3,4,5)P4 and Ins(1,4,5)P3, are capable of
binding to the PTPLP active sites in a catalytically competent manner [159, 169]. Fur-
ther, various IPases have been demonstrated as important for the function and survival
of pathogenic bacteria in host systems [2, 32, 100]. They function by either providing
the phosphate for growth or by derangement of the host phosphatidylinositol signalling
pathway [32, 100]. This suggest PTPLP virulence factors disrupt phosphatidylinositide
or inositol phosphate signaling pathways as opposed to phosphotyrosine-mediated path-
ways [2, 180, 181].
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Chapter 3
The tandemly repeated protein tyrosine
phosphatase-like myo-inositol
phosphatase from Mitsuokella multacida
in complex with Ins(1,2,4,5,6)P5 displays
divergent myo-inositol phosphate activity
3.1 Introduction
myo-inositol phosphates (IPs) are a derivative of myo-inositol that contain between
one and eight phosphoryl groups with the most abundant being myo-inositol-1,2,3,4,5,6-
hexakisphosphate (InsP6 or phytate) [5, 23]. InsP6 has diverse roles within eukarytoic cells
and the importance is emphasized by the observation that deletions of enzymes involved in
InsP6 biosynthesis have lethal phenotypes in mouse embryos [18,33,34,182]. The roles of
myo-inositol pentakisphosphates (InsP5) have more recently been investigated and shown
to be involved in hormone signaling, affecting cell proliferation rates, modulating apop-
totic responses, regulating viral assembly, chromatin remodeling, calcium channel activity,
cytoskeleton reorganization, functioning as a hemoglobin effector, and functioning as a pre-
cursor to several metabolites [18,45,47,49–57]. Enzymes specific for IPs are found within
prokaryotic organisms despite the absence of IPs from most prokaryotic cells [8, 171].
These enzymes have characterized roles in phosphate scavenging, pathogenesis, and hy-
drolyzing dietary InsP6 in the mammalian gut [2, 32, 99, 100, 183].
Protein tyrosine phosphatase-like myo-inositol phosphatases (PTPLPs) can remove one
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or more phosphoryl groups from IPs, producing inorganic phosphate and Ins(2)P or another
lesser phosphorylated IP [157, 158, 165, 170, 184]. The phosphoryl group in the 2-position
is unique as it is axial while the other five are equatorial in the lowest energy chair con-
formation [37, 38]. Of the PTPLPs characterized to date, five remove the C3-phosphoryl
group from InsP6 (3-phytases) [158, 165, 170, 184, 185], one removes the C5-phophoryl
group (5-phytases) [157], and one the C1-phosphoryl group (1-phytase) [161].
PTPLPs are composed of a catalytic α-β-α sandwich PTP domain and an antiparallel
α-β sandwich Phy-specific domain [162]. The catalytic PTP domain contributes the general
acid loop (GA-loop) and phosphate-binding loop (P-loop) from the catalytic PTP domain,
while residues from both the PTP and Phy-specific domains participate in substrate bind-
ing [166, 184]. Three loops adjacent to the active site have been shown to contribute to
the specificity of PTPLPs: the Ω-loop, the β-hairpin (C-terminal repeat) and α-turn (N-ter-
minal repeat) of the Phy-specific domain, and the extended loop prior to the penultimate
helix [184]. These loops share limited sequence identity, vary in length, and adopt distinct
conformations in structurally characterized PTPLPs [184]. The different loop conforma-
tions affect substrate access and available space within the active site. In general, the more
open and accessible PTPLP active sites have a more relaxed substrate specificity towards
less-phosphorylated substrates [184]. The PTPLP from Mitsuokella multacida (PhyAmm)
is a homodimer and each monomer is a tandemly repeated PTPLP that contains two copies
of the catalytic PTP and Phy-specific domains [169, 184]. The PhyAmm dimer interface
is almost exclusively formed between the N-terminal repeats as an extensive network of
hydrogen bonds, salt bridges, and van der Waals contacts [169, 184].
Here we present the first structure of a PTPLP (PhyAmm) in complex with Ins(1,2,4,5,6)-
P5. In this structure, an inorganic phosphate is bound to the N-terminal repeat and Ins(1,2,-
4,5,6)P5 is bound to the C-terminal repeat of the inactive PhyAmmC250S/C548S mutant.
This work presents the structural features that determine the conformation of the variable
loops adjacent to the active site that influence the substrate specificity of PTPLPs. Further,
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a novel IP specificity assay is presented which was used to identify the preferred substrates
of the PhyAmm repeats, revealing that their specificities diverge and display a “divide and
conquer” approach to InsP6 hydrolysis.
3.2 Experimental procedures
3.2.1 Cloning and mutagenesis
The phyA gene of M. multacida, minus the putative signal peptide, was previously
cloned into the NdeI site of the pET28bKan expression vector (EMD Biosciences) to add an
N-terminal His6 tag [169]. All mutant proteins (PhyAmmC250S/C548S, PhyAmmC250S,
and PhyAmmC548S) were created by site-directed mutagenesis using counter-PCR ampli-
fication of the expression plasmid as described previously [186]. To confirm the presence
of the desired mutations the nucleotide sequences were analyzed at the McGill University
and Genome Quebec Innovation Centre.
3.2.2 Expression and purification
Protein expression was carried out in Escherichia coli T7 Express Competent cells (New
England Biolabs; NEB) in ZYM-505 media supplemented with 50 µg/mL kanamycin. Cells
were grown to an optical density (600 nm) of 3.0 at 310 K when protein expression was
induced by adding isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of
1 mM and grown overnight at 293 K. The induced cells were harvested and resuspended
in lysis buffer (20 mM KH2PO4 pH 7.0, 300 mM NaCl, 5 mM β-mercaptoethanol (BME),
25 mM imidazole (pH 8.0), lysed by sonication, and cell debris was removed by centrifu-
gation at 24 700 × g (45 min).
All proteins were purified to homogeneity by metal chelating affinity chromatography
(Ni2+-NTA-agarose, Bio-Rad) as previously described [165,169]. PhyAmmC250S/C548S
was further purified for crystallization by cation exchange (Bio-Scale S Column, Bio-Rad)
and size exclusion chromatography (S200, GE Healthcare) as described previously [165,
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166, 169, 184]. The PhyAmm (C250S and C548S) cysteine to serine mutations (isosteric
subsitution) result in inactivation of both active sites.
3.2.3 IP production
The Ins(1,2,4,5,6)P5 was produced enzymatically and purified to greater than 99% pu-
rity as shown in Figure 3.1. A 700 MHz Bruker Avance III NMR Spectrometer solution
state nuclear magnetic resonance (NMR) spectrometer was used. After referencing the
spectrometer with 85% phosphoric acid, the 31P (1H decoupled) spectra for the 10 mM
Ins(1,2,4,5,6)P5 samples in the presence of 0.1 M NaOH were collected at 293 K.
Figure 3.1: 31P (1H decoupled) spectra of 5 mM purified Ins(1,2,4,5,6)P5.
3.2.4 Crystallization
Crystallization experiments were conducted at room temperature using sitting-drop va-
pour diffusion with drop ratios of 2 µL protein solution to 2 µL reservoir solution. PhyAmm-
C250S/C548S protein solutions were prepared at 4.5 mg/mL, and crystals were grown as
described previously [184]. After 30 days rod-like crystals grew with approximate dimen-
sions of 100 × 100 × 500 µm. Crystals were soaked in mother liquor supplemented with
10 mM Ins(1,2,4,5,6)P5 (produced enzymatically) for 15 minutes, and the crystals were
flash-frozen in liquid nitrogen.
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3.2.5 Data collection and image processing
Diffraction data (λ = 0.97925 A˚) was collected from frozen crystals (100 K) using a
Rayonix MX300 CCD detector at beamline 08ID-1 located at the Canadian Light Source
(CLS; Saskatoon, SK, Canada). The space group and unit cell parameters are equivalent to
those of the PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure (PDB 4WU3). All diffraction
image data were processed interactively with MOSFLM prior to scaling and merging within
AIMLESS of the CCP4 program suite, version 6.3.0 [172–175]. Data collection statistics
are shown in Table 3.1.
3.2.6 Structure refinement and model validation
Phases derived from the PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure (PDB 4WU3)
were used to solve the structures by molecular replacement. The refined structures have
continuous electron density for main-chain atoms of amino acids 47 to 637, with the remain-
ing residues located at the termini assumed to be disordered. This includes the N-terminal
histidine tag and residues 31 to 46. Refinement was performed using PHENIX, version
1.11.1-2527, while interactive fitting of the models to the electron density were performed
in COOT, version 0.8.8 [176,187]. PROCHECK and structure validation tools with COOT
were used throughout refinement to assess the stereochemistry of the model [177]. Unless
indicated otherwise, figures were prepared with CCP4mg, version 2.10.8 [178]. Key data
processing and refinement statistics are presented in Table 3.1.
3.2.7 Structure analysis
PhyAmmC250S/C548S and previously determined structures were compared by least
squares (LSQ) superposition using LSQKAB from the CCP4 program suite [173]. The
main-chain atoms of residues 47 to 342 and 343 to 636 for the N- and C-terminal repeats
of PhyAmmC250S/C548S, respectively, were used in overall fold comparisons. Active-site
comparisons were made using residues 350 to 351, 448 to 450, 484 to 486, 517 to 522, 545
to 558, 584 to 586, and 599 to 608 of the PhyAmmC250S/C548S C-terminal repeat. Dif-
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Table 3.1: Data collection and refinement statistics for the PhyAmmC250S/C548S·Ins-
(1,2,4,5,6)P5 structure.
1
PhyAmmC250S/C548S
Ins(1,2,4,5,6)P5
Data collection
Space group P1
a, b, c (A˚) 74.4, 86.5, 123.5
α, β, γ (◦) 107.3, 91.6, 90.1
Wavelength (A˚) 0.97925
Resolution (A˚) 45.51 - 2.4 ( 2.486 - 2.4 )
Observed reflections 205 848
Unique reflections 103 981
Completeness (%) 90.4 ( 83.6 )
Redundancy 2.0
Rmerge (%) 11.2 (37.4)
I / σI 2.1
Refinement Statistics
No. reflections work set 103 953
No. reflections test set 4950
Rwork / Rfree (%) 20.7 / 25.2 ( 28.7 / 36.6 )
Asymmetric unit Dimer of Dimers
Protein atoms 19 172
Solvent atoms 681
Ligand atoms 168
Wilson B (A˚2) 26.1
Average B protein (A˚2) 35.1
Average B solvent (A˚2) 29.7
Average B ligand (A˚2) 46.5
RMSD Bonds (A˚) 0.004
RMSD Angle (◦) 0.900
Ramachandran distribution
Preferred (%) 96.77
Allowed (%) 3.23
Outliers (%) 0
1 values in parenthesis are for the highest resolution shell
ferences in the relative position of the myo-inositol ring of bound ligands of PhyAsrC252S
were calculated using the superposed structures produced by secondary structure matching
(SSM) within COOT, and GEOMCALC in the CCP4 program suite [173, 176, 177].
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3.2.8 Identification of hydrolysis products
Hydrolysis of 5 mM InsP6 (Sigma-Aldrich) was carried out at room temperature in
the presence of PhyAmmC250S (10 nM) or PhyAmmC548S (500 nM) (50 mM sodium
acetate pH 5.0, 200 mM NaCl, 1 mM BME, 0.1 mM EDTA). Reactions were quenched
with an equal volume of 5% trichloroacetic acid (TCA) and subjected to high performance
ion chromatography (HPIC; Waters 1525 Binary HPIC Pump; Milford, MA) utilizing a
CarboPac PA-100 (4 × 240 mm) analytical column (Dionex; Sunnyvale, CA) [179] at
room temperature using a post-column reactor flow rate of 0.2 mL/min. Identification of
hydrolysis products utilized a standard hydrolysis chromatogram (appendix A experimental
procedures).
3.2.9 IP Specificity Assay
The 11 hour acid hydrolysis sample was produced by following the methodology of
Blaabjerg et al. (2010) [179]. Briefly, partial hydrolysis of InsP6 was performed by boiling
1.5 g InsP6 with 100 mL of 0.5 M HCl for 11 hours. The solution was evaporated to
dryness and the residue was dissolved to 30 mg/mL in a 50 mM sodium acetate (pH 5.0),
200 mM NaCl, 1 mM BME, and 0.1 mM EDTA buffer. Peak assignment was performed by
referencing the chromatograms to the peak identities determined by Blaabjer et al. (2010)
[179,184].
The activities of PhyAmm (100 nM), PhyAmmC250S (100 nM), and PhyAmmC548S
(200 nM) were determined against the 11 hour acid hydrolysis mixture. The proteins were
incubated with 30 mg/mL of the 11 hour acid hydrolysis, the reaction quenched with an
equal volume of 5% TCA and analyzed using a CarboPac PA-100 analytical column with a
methanesulfonic acid gradient [179, 184]. IPs were visualized using a post-column reactor
with 0.1% (m/v) Fe(NO3)3 in a 2% (m/v) HClO4 solution (0.2 mL/min).
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3.3 Results
3.3.1 Ins(1,2,4,5,6)P5 binding is consistent with the hydrolysis pathway
The PhyAmmC250S/C548S·Ins(1,2,4,5,6)P5 structure presented here is isomorphous
with the PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure previously published (Figure 3.2;
Table B.1) [184]. The C-terminal active site is virtually identical in the presence and ab-
sence of ligand, and between space groups, supporting the observation that the PTPLP fam-
ily of enzymes have pre-formed active sites (Table B.2) [166, 184]. The electron density
for Ins(1,2,4,5,6)P5 and inorganic phosphate bound within the C-terminal and N-terminal
active sites, respectively, is visible in initial 2mFo–DFc (1.5 σ) and mFo–DFc (3.5 σ) maps,
consistent with previous studies [169,184]. Modeling Ins(1,2,4,5,6)P5 as partial occupancy
(0.70 occupancy) with inorganic phosphate (0.30 occupancy) in the C-terminal active-site
reduces the difference density found within the active site and improves the overall qual-
ity of the density resulting in the refined 2mFo – DFc (1 σ) electron density seen in Fig-
ure 3.3 [166]. Consistent with previous PTPLP structures in complex with ligand, the
modeled Ins(1,2,4,5,6)P5 adopts the lowest-energy chair conformation with five equatorial
hydroxyl/phosphoryl groups and an axial C2-phosphoryl group.
Clear electron density for the axial C3-hydroxyl and each phosphoryl group identifies
the Ins(1,2,4,5,6)P5 ligand and its orientation within the active site of the C-terminal re-
peat. To facilitate the discussion of substrate conformation within the active site, the six
phosphoryl-binding sites identified in the structure of PhyAsrC252S in complex with InsP6
complex will be used and are referred to as the Ps, Pa, Pb, Pa′ , and Pb′ sites [166]. Consistent
with the known InsP6 hydrolysis pathway, the C4-phosphoryl group is located within the
catalytic Ps site where it forms extensive contacts with P-loop (Figure 3.4; Table 3.2) [184].
The C3-hydroxyl of Ins(1,2,4,5,6)P5 is located on the Pa′/Pb′ side of the active site and
makes a novel interaction with Gln-549 of the P-loop. This allows the axial C2-phosphoryl
group to fill the Pa′ site where it makes multiple contacts with Arg-351 and Lys-485 of the
Phy-specific domain. The remaining C5, C6 and C1 phosphoryl groups occupy the Pa, Pb
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Figure 3.2: Ribbon diagram of the overall fold of PhyAmmC250S/C548S in complex with
InsP5. A PhyAmm oriented to view the tandem repeats and linker resulting in the InsP5
ligand viewed from the top with the P-loop below the ligand. Within each catalytic PTP
domain are the P-loop (yellow; residues 250 to 257 and 548 to 555) and GA-loop (cyan;
residues 220 to 223 and 518 to 521). The Phy-specific domain (residue ranges 53 to 61 and
132 to 201, and 345 to 353 and 432 to 499) and the Phy-specific extension of the penultimate
helix (green; residues 286 to 301 and 583 to 600) are unique to PTPLPs. B The PhyAmm
dimer oriented to view the dimer interface formed primarily between the N-terminal re-
peats. The ligand atoms are shown as sticks in black. The polypeptide chains are shown in
grey. The variable loops include the extended loops prior to the penultimate helix (green),
the α-turn and β-hairpin turns (blue), and the extended Ω-loops (red). The P-loop (yel-
low) and the general-acid loop (GA-loop; cyan) contribute catalytic residues. Mutation of
the cysteine nucleophile to the isosteric serine prevents thiolate formation and renders the
enzyme inactive.
and Pc sites, respectively, while the Pb′ site remains empty.
3.3.2 Structural features determining specificity of the C-terminal repeat
The structure of Ins(1,2,4,5,6)P5 in complex with PhyAmmC250S/C548S is the first
example of an InsP6 hydrolysis product in complex with a PTPLP and directly tests the
hypothesis that the variable loops adjacent to the active site influence the substrate speci-
ficity of PTPLPs (Figure 3.2). In the C-terminal repeat, substrate access to the Pa′/Pb′
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Figure 3.3: Clear electron density for A the inorganic phosphate, and B the phosphoryl
groups and C3-hydroxyl of Ins(1,2,4,5,6)P5 allow for an unambiguous fit of the ligands
above the cysteine to serine mutations at position 250 (N-terminus) and 548 (C-terminus).
The fit of Ins(1,2,4,5,6)P5 places the C4-phosphoryl group (P4) in direct contact with the
P-loop in a catalytically competent manner. The refined 2mFo – DFc electron density, con-
toured at 1σ (blue mesh) for PhyAmmC250S/C548S in complex with inorganic phosphate
and InsP5. Ligand and protein are shown as sticks with oxygen shown in red, nitrogen in
blue, phosphorus in orange, and carbon in grey.
Figure 3.4: The C-terminal repeat of PhyAmmC250S/C548S binds Ins(1,2,4,5,6)P5 using
a subset of the contacts identified in the PhyAsrC252·InsP6 (PDB 3MMJ) structure [166].
The phosphoryl-binding sites are labeled according to the InsP6 structure (Ps, Pa, Pb, Pa′,
and Pc). Residues that interact with the ligands are derived from the P-loop (yellow),
GA-loop (cyan), Phy-specific domain, and penultimate helix. Oxygen is shown in red,
nitrogen in blue, phosphorus in orange, and carbon in grey.
phosphoryl-binding sites is reduced as a result of the conformation of the β-hairpin loop
of the Phy-specific domain that extends over the Pb′ site (Figure 3.5). In contrast, the Pa
and Pb sites are relatively accessible as the extended loop prior to the penultimate helix is
directed away from the active site. Consistent with the model, the Ins(1,2,4,5,6)P5 substrate
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Table 3.2: Electrostatic and hydrogen bond distances in the PhyAmmC250S/C548S·InsP5
structure. Contact distances (<3.4 A˚) between PhyA and the ligand phosphoryl (Phos) and
hydroxyl (-OH)) groups are shown. Bolded distances are main-chain interactions.
Residue Site Phos / -OH Distance (A˚)
Arg-351 Pa′ P2 3.40 / 2.99
Lys-485 Pa′ P2 3.10 / 3.13
Pc P1 2.64
Asp-519 Pa′ P2 3.04
Ser-548 Ps P4 2.19
Gln-549 Ps P4 3.25
Pa′ P2 3.17
O3 2.90
Gly-551 Ps P4 3.27
Ala-552 Ps P4 3.09
Gly-553 Ps P4 3.29 / 3.19
Pa P5 3.37
Arg-554 Ps P4 2.80 / 3.09 / 2.81
Asn-585 Pb P6 3.31
Lys-600 Pc P1 3.18
Lys-607 Pa P5 3.22
is bound with the C2-phosphoryl group and C3-hydroxyl on the relatively occluded Pa′/Pb′
side of the active site while the Pa and Pb sites are filled by the C5- and C6-phosphoryl
groups, respectively (Figure 3.4). The orientation of the Ins(1,2,4,5,6)P5 myo-inositol ring
and the C1-C2-O2-P2 torsion angle allows the C2-phosphoryl to fill the Pa′ site. This max-
imizes the number of favourable electrostatic contacts with the substrate as the Ps, Pa, Pb
and Pa′ sites account for virtually all direct contacts in this structure (Table 3.2).
In addition to the variation of the loops adjacent to the active site, there are two residues
that are unique to the C-terminal repeat that would likely affect substrate specificity: Gln-549
and Asn-585. In the case of Gln-549, the side chain is directed towards the active site where
it contributes to the occlusion of the Pa′/Pb′ side of the active site and makes multiple in-
teractions with the axial C2-phosphoryl group and the C3-hydroxyl (Table 3.2). Asn-585
contacts the C6-phosphoryl group bound in the Pb site, stabilizing the orientation of the
bound Ins(1,2,4,5,6)P5 substrate with a pair of equatorial phosphoryl groups in the Pa and
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Figure 3.5: Superposition of the N- (light coloured loops) and C-terminal (dark coloured
loops) repeats of the PhyAmmC250S/C548S·InsP5 structure as a ribbon diagram with the
ligand as sticks. The variable loops (colored segments) that influence substrate specificity
include the extended loop prior to the penultimate helix (green), the extended Ω-loop (red),
and the β-hairpin and α turns (blue) within the Phy-specific domain.
Pb sites and the C4-phosphoryl group positioned for hydrolysis in the Ps site. Consequently,
the relatively small Asn-585 results in an increased accessibility on the Pa/Pb side of the ac-
tive site while contributing a favourable interaction that selects for the observed orientation
of the substrate. Together, these residues contribute to the more occluded Pa′/Pb′ side and
more accessible Pa/Pb side of the active site, while providing favourable interactions that
stabilize the observed orientation of the substrate with the C4-phosphoryl in the Ps site.
3.3.3 N-terminal active-site structure predicts different substrate specificity than the
C-terminal active site
As demonstrated both in previous and current work, the N- and C-terminal repeats have
distinct activities towards IPs [169, 184]. In accordance with these differences, the size
and conformation of the variable loops adjacent to the active site of the N-terminal re-
peat diverge from those of the C-terminal repeat, predicting divergent substrate specificities
(Figure 3.5). The Ω-loop of the N-terminal repeat is seven residues shorter than Ω-loop
of the C-terminal repeat and does not directly affect the active-site structure. The size dif-
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ference is smaller in the remaining two loops, with the N-terminal repeat α-turn of the
Phy-specific domain containing two additional residues than the equivalent β-hairpin turn
of the C-terminal repeat, while the extended loop prior to the penultimate helix contains two
fewer residues in the N-terminal repeat than the C-terminal repeat. The additional residues
of the α-turn extend over the Pb′ site and are shifted towards the P-loop (Figure 3.5). In
this conformation the α-turn severely restricts access to the Pb′ site and would sterically
prevent InsP6 binding. Consequently, the α-turn conformation of the Phy-specific domain
is likely responsible for the low activity of the N-terminal repeats towards InsP6 and InsP5
substrates [169]. Finally, conformation of the extended loop prior to the penultimate helix
and the longer penultimate helix of the N-terminal repeat is stabilized by the dimer inter-
face which prevents the loop from restricting access to the Pa/Pb side of the active site as is
seen in the C-terminal repeat (Figure 3.5). The conformation of the variable loops result in
a more occluded Pa′/Pb′ side and a more accessible Pa/Pb side of the active site.
In addition to variations in the loops adjacent to the active site and the penultimate
helix, there are multiple point mutations within the active site that likely influence substrate
binding (Table 3.3). Three of the point mutations cluster about the Pa′/Pb′ sites where they
reduce the number of potential interactions from the Pa′ site and occlude the Pb′ site. In
particular, Tyr-251 in the P-loop replaces the structurally equivalent Gln-549 of the C-termi-
nal repeat, while Lys-59 and Asn-187 of the N-terminal repeat Phy-specific domain replace
Arg-351 and Lys-485, respectively. The larger Tyr-251 side chain is directed away from
the active site and forms a hydrogen bond with Asp-184 of the α-turn. As a result, Tyr-251
cannot replicate the multiple favourable interactions between Gln-549 and the substrate
observed in the C-terminal repeat (Table 3.2). Likewise, the shorter Lys-59 side chain
forms a hydrogen bond with Asp-61 and is unlikely to form the interactions seen in the
C-terminal between Arg-351 and the substrate. As a result of these substitutions, the Pa′
site of the N-terminal repeat is expected to make half as many interactions with bound
substrates than seen in the more active C-terminal repeat. The remaining mutation on the
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Pa′/Pb′ side of the active site occurs in the α-turn of the Phy-specific domain. The different
conformations of the α-turn and β-hairpin turn of the Phy-specific domain allow the amide
side chain of the shorter Asn-187 in the N-terminal repeat to superpose with the Lys-485
amine of the C-terminal repeat. While this substitution preserves a likely Pa′ interaction, it
facilitates a shift of the main chain towards the P-loop, which severely restricts access to
the Pb′ site.
Table 3.3: Structurally equivalent residues of the PhyAmm N- and C-terminal active sites
that interact with the IP substrates (or are expected to do so in the N-terminal active site).
Bolded residues show differences in the active sites.
PhyAmm
N-terminus
Phosphoryl
Binding site
PhyAmm
C-terminus
Lys-59 Pa′ Arg-351
Arg-70 Pb′ Arg-362
Asp-149 Pa′ Asp-449
Asn-187 Pa′ /Pc Lys-485
Asp-221 Pa′ Asp-519
His-222 Pa His-520
Cys-250 Ps Cys-548
Tyr-251 Ps Gln-549
Ala-252 Ps Ala-550
Gly-253 Ps Gly-551
Met-254 Ps Ala-552
Gly-255 Pa Gly-553
Arg-256 Ps Arg-554
Val-288 Pb Asn-585
Gly-301 Pc/Pb Lys-600
Tyr-305 Pb Tyr-604
Arg-308 Pa Lys-607
The remaining mutations are located on the Pa/Pb side of the active and involveMet-254,
Val-288, Gly-301 and Arg-308 (Table 3.3). As a result of these mutations, it is likely that
phosphoryl groups bound in the Pa and Pb sites of the N-terminal repeat are shifted to-
wards to GA-loop resulting in the substrate binding deeper in the active site. Gly-301 of the
extended loop replaces Lys-600 of the C-terminal repeat and removes any potential inter-
action from this position to the Pb site. Together with the differences in the extended loop
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conformation, this substitution creates a large space adjacent to the GA-loop (Figure 3.6).
At the same time, the large Met-254 side chain replaces Ala-552 of the P-loop and in the
observed conformation it is likely to make close contacts with phosphoryl groups bound to
the Pb site. While the conformation of the Met-254 side chain may change in the presence
of substrate, the Gly-301 substitution suggests that phosphoryl groups bound to the Pb site
may shift towards the open space adjacent to the GA-loop. The N-terminal repeat Arg-308
replacement of Lys-607 is also likely to create too close contacts with phosphoryl groups
bound to the Pa site. Since the conformation of the Arg-308 side chain is fixed by multiple
packing interactions, phosphoryl groups bound to the the Pa site are likely to shift towards
the GA-loop. Finally, Val-288 cannot replace the Asn-585 contribution to the Pa site. Taken
together, the mutations on the Pa/Pb side of the active site significantly alter the shape of
the active site. Close contacts involving the Pa and Pb sites with the additional open space
adjacent to the GA-loop suggest the Pa and Pb sites are shifted towards the GA-loop of the
N-terminal repeat.
3.3.4 The PhyAmm N- and C-terminal repeats have divergent IP activity
The N- and C-terminal repeats of PhyAmm have different activities towards InsP6 and
InsP5 substrates. Specifically, the N-terminal repeat has less than 2% of the activity of the
C-terminal repeat towards InsP6 and InsP5 [169]. Given the observed difference in the ac-
tive site structure of the N- and C-terminal repeats, the InsP6 hydrolysis pathway of both
domains were determined (Figure 3.7). The active C-terminal repeat (PhyAmmC250S)
produces a major (>90%) and minor InsP5 product that have been identified as DL-Ins-
(1,2,4,5,6)P5 and DL-Ins(1,2,3,5,6)P5, respectively (Figure 3.7 A). Subsequent reactions
convert the major DL-Ins(1,2,4,5,6)P5 product to DL-Ins(1,2,5,6)P4 and DL-Ins(1,2,6)P3
along the major hydrolysis pathway and DL-Ins(1,2,3,5,6)P5 to DL-Ins(1,2,3,6)P4 along
the minor pathway. These results are nearly identical to those previously generated for
the fully active enzyme, less the minor pathway products [184]. The active N-terminal re-
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Figure 3.6: Stereo view of the A N- and B C-terminal repeats of the PhyAmmC250S/-
C548S·InsP5 structure as a space-filling diagram with the ligand as sticks. The view em-
phasizes the space at the back of the active site adjacent to the GA-loop which is either
filled (C-terminal repeat) or open (N-terminal repeat). The variable loops (colored seg-
ments) that influence substrate specificity include the extended loop prior to the penulti-
mate helix (green), the extended Ω-loop (red), and the β-hairpin and α turns (blue) within
the Phy-specific domain. The ligand has been superposed onto the N-terminal repeat for
comparison.
peat (PhyAmmC548S) produces the same InsP5, InsP4 and InsP3 peaks, though the precise
enantiomers have yet to be determined (Figure 3.7 B).
The accumulation and subsequent hydrolysis of InsP5 through InsP2 differs for the in-
dividual repeats indicating divergent activities (Figure 3.7). In the case of the C-terminal
repeat, each of the major pathway hydrolysis products accumulate to relatively high lev-
els prior to the formation of the subsequent IP product. The sequential accumulation of
C-terminal repeat products as a function of time suggest the rates of catalysis of the indi-
vidual steps are comparable or decrease for each lesser-phosphorylated product. The InsP6
hydrolysis pathway of the N-terminal repeat has a similar pattern of product accumulation
and subsequent hydrolysis for InsP5 and InsP4. This pattern diverges for InsP3 and InsP2, as
the InsP2 peak accumulates more rapidly. This suggests the efficiency of InsP3 hydrolysis
is significantly larger than that of the other IPs.
To further understand the substrate specificity of the individual repeats of PhyAmm,
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Figure 3.7: HPIC chromatograms of the PhyAmmC250S (A) and PhyAmmC548S (B) InsP6
hydrolysis products. InsP6 (5 mM) was incubated with 10 nM PhyAmmC250S and 500 nM
PhyAmmC548S at room temperature. Samples were taken at 0 min (black), 10 min (blue),
20 min (orange), 30 min (red), 40 min (green), 50 min (purple), and 60 min (cyan), and
separated using a CarboPac PA-100 analytical column with a methanesulfonic acid gradient
[20, 179]. IPs were visualized using a post-column reactor with 0.1% (m/v) Fe(NO3)3 in a
2% (m/v) HClO4 solution (0.2 mL/min).
each repeat was incubated with an IP mixture generated by incomplete acid hydrolysis and
followed as a function of time (Figure 3.8; Table 3.4). While the analysis of hydrolysis data
for complex mixtures is more challenging, chromatographic peaks that increase in area are
products, those that decrease are substrates, and those that remain constant are either un-
affected by the enzyme or are produced and consumed at equal rates. The time course of
hydrolysis for the fully active PhyAmm (Figure 3.8 A) suggests the vast majority of the
possible IPs can be hydrolyzed to a greater or lesser extent and clearly demonstrates the
enzyme has activity towards substrates that are not present in the InsP6 hydrolysis path-
way. As summarized in Table 3.4, InsP6 and the InsP5 substrates are rapidly hydrolyzed
and their concentrations decrease at each time point until they have been completely hy-
drolyzed. The InsP4 and InsP3 substrates typically accumulate during initial time points
and are subsequently hydrolyzed, while the InsP2 (peaks 1-5) and several InsP3 substrates
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accumulate at all measured time points. The overall trend is consistent with an enzyme that
has a higher activity towards highly phosphorylated substrates and a lower activity towards
less phosphorylated substrates. While there is no evidence the InsP2 and several InsP3
substrates are hydrolyzed under these conditions, prolonged incubation will likely result in
additional hydrolysis of these substrates as has been demonstrated in previous work [169].
Table 3.4: Summary of the activity of wild-type PhyAmm, PhyAmmC250S and PhyA-
mmC548S against the 11 hour acid hydrolysis mixture. The wild-type PhyAmm and
PhyAmmC250S at 100 nM, and PhyAmmC548S at 200 nMwere incubated with 20 mg/mL
of the 11 hour acid hydrolysis for up to one hour (Figure 3.8). ↑ and ↓ indicates an increase
and decrease in peak size, respectively, ∅ indicates no detectable activity, and C indicates
complete peak disappearance in 60 minutes. The peaks were identified according to Blaab-
jerg et al. (2010) [179,184].
Chromatogram myo-inositol PhyAmm
PhyAmmC250S PhyAmmC548S
Peak Number1 phosphate2 wild-type
0 PO4 ↑ ↑ ↑
1 - 4 InsP2 ↑ ↑ ↑ ↓
5 InsP2 ↑ ↑ ↑ ↓
6 - 11
InsP3 ↑ ↑ ↓
InsP3 ↓ ↑ ↑ ↓ ↑
InsP3 ↑ ↓ ↑ ↓ ↓
12 DL-Ins(1,5,6)P3 ↓ ↓ ↓
13 DL-Ins(4,5,6)P3 ↑ ↓ ↑ ↓ C
14 - 15
Ins(1,2,3,5)P4
↓ ↓ C ↓
DL-Ins(1,2,4,6)P4
16 - 17
DL-Ins(1,2,3,6)P4
↑ ↓ ↑ ↓ ↓
Ins(1,3,4,6)P4
18 DL-Ins(1,2,4,5)P4 ↓ C ↓ C ∅
19 DL-Ins(1,3,4,5)P4 ↓ C ↓ C ∅
20 DL-Ins(1,2,5,6)P4 ↑ ↓ ↑ ↓ C ↓ ↑
21 Ins(2,4,5,6)P4 ↑ ↓ C ↑ ↓ C ↑
22 DL-Ins(1,4,5,6)P4 ↑ ↓ ↑ ↓ ↓
23 Ins(1,2,3,4,6)P5 ↓ C ↓ C ↓
24 DL-Ins(1,2,3,4,5)P5 ↓ C ↓ C ↑ ↓
25 DL-Ins(1,2,4,5,6)P5 ↓ C ↓ C ↑
26 Ins(1,3,4,5,6)P5 ↓ C ↓ C ∅
27 InsP6 ↓ C ↓ C ↓
1identified in Figure 3.8
2as identified by Blaabjerg et al. (2010) [179]
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Figure 3.8: HPIC chromatograms of the activities of wild-type PhyAmm (A), PhyAmm-
C250S (B) and PhyAmmC548S (C) against the 11 hour acid hydrolysis mixture. The
wild-type PhyAmm and PhyAmmC250S at 100 nM, and PhyAmmC548S at 200 nM were
incubated with 20 mg/mL of the 11 hour acid hydrolysis for 10 min (blue), 20 min (or-
ange), 30 min (red), 40 min (green), 50 min (purple), and 60 min (cyan). Production of
the 11 hour acid hydrolysis sample (black) as performed previously [179, 184]. The peaks
are identified by Blaabjerg et al. (2010) [179] as: (1-5) InsP2, (6-11) InsP3, (12) DL-
Ins(1,5,6)P3, (13) DL-Ins(4,5,6)P3, (14) Ins(1,2,3,5)P4, (15) DL-Ins(1,2,4,6)P4, (16) DL-
Ins(1,2,3,6)P4, (17) Ins(1,3,4,6)P4, (18) DL-Ins(1,2,4,5)P4, (19) DL-Ins(1,3,4,5)P4, (20)
DL-Ins(1,2,5,6)P4, (21) Ins(2,4,5,6)P4, (22) DL-Ins(1,4,5,6)P4, (23) Ins(1,2,3,4,6)P5, (24)
DL-Ins(1,2,3,4,5)P5, (25) DL-Ins(1,2,4,5,6)P5, (26) Ins(1,3,4,5,6)P5, (27) InsP6. The IPs
were separated using a CarboPac PA-100 analytical column with a methanesulfonic acid
gradient [179, 184]. IPs were visualized using a post-column reactor with 0.1% (m/v)
Fe(NO3)3 in a 2% (m/v) HClO4 solution (0.2 mL/min).
In the case of the active C-terminal repeat (PhyAmmC250S; Figure 3.8 B), the time
course of hydrolysis is similar to that observed for the fully active PhyAmm, in agree-
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ment with the C-terminal repeat having higher activity when compared with the N-terminal
repeat. The most notable differences include a greater accumulation of InsP3 and InsP2
products that are not subsequently hydrolyzed under these conditions. Of particular inter-
est, peaks that differ between the fully active PhyAmm and the active C-terminal repeat
include those peaks that are efficiently hydrolyzed by the N-terminal repeat. This strongly
suggests the activity of the fully active PhyAmm is approximately the sum of the activity
of the individual repeats and likely represents a mechanism to maximize the removal of
phosphoryl groups in a mixed IP environment.
The active N-terminal repeat (PhyAmmC548S) has limited or no activity towards InsP6,
InsP5 and InsP4 substrates, and exhibits its greatest activity towards the InsP3 and InsP2 sub-
strates (Figure 3.8 C). The InsP3 peaks decrease throughout the time course with the excep-
tion of a single InsP3 peak representing Ins(1,2,3)P3, DL-Ins(1,2,6)P3 and DL-Ins(1,4,6)P3
(middle peak of peak 8-11), which undergoes a rapid initial decrease and followed by a
much smaller accumulation late in the time course. The same InsP3 peak is produced in the
active N-terminal repeat InsP6 hydrolysis pathway where it is rapidly converted to an InsP2
product. The small accumulation of this peak late in the time course of the IP mixture likely
arises from the limited activity of the N-terminal repeat towards InsP4 peaks that are not
generated as part of the InsP6 hydrolysis pathway. This suggests at least one of the InsP3
components of this peak are not efficiently hydrolyzed.
Finally, while there is evidence the C-terminal repeat has a higher activity towards InsP6
and InsP5 substrates than the fully active enzyme, this may simply reflect batch-to-batch
variation in the effective concentration of the enzyme preparations. At this time, we cannot
rule out alternative explanations, including differential sensitivity to oxidants, differences
in potential inhibitory mechanisms and/or cooperativity between active sites.
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3.4 Discussion
3.4.1 myo-inositol ring position allows for optimal use of the PhyAmm C-terminal
repeat phosphoryl-binding sites
The PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure presented here is isomorphous with
the PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure published previously, and a compari-
son of the substrates bound in the two structures reveals changes in the relative orientation
of the myo-inositol ring (Figure 3.9; Table 3.5) [184]. The Ins(1,3,4,5)P4 substrate binds
with the opposite face of the myo-inositol ring towards the GA-loop when compared to the
Ins(1,2,4,5,6)P5 binding observed in this work [184]. This directs the axial C2-hydroxyl
away from the GA-loop and allows the equatorial C3-phosphoryl group to fill the Pa′ site.
In the Ins(1,2,4,5,6)P5 structure, the myo-inositol ring is rotated away from the GA-loop,
allowing the axial C2-phosphoryl to fill the Pa′ site while the C4-phosphoryl group occu-
pies the Ps site (Figure 3.9; Table 3.5). As a result, Ins(1,2,4,5,6)P5 binds to the Ps, Pa, Pb,
Pa′ and Pc sites of PhyAmmC250S/C548S with an orientation that is more similar to that
observed in the PhyAsrC252S· InsP6 complex structure (Figure 3.9; Table 3.5).
Figure 3.9: Modeling of PhyAmmC250S/C548S·Ins(1,2,4,5,6)P5 (green) with the
substrates from the PhyAmmC250S/C548S·Ins(1,3,4,5)P4 (orange; PDB 4VU3) and
PhyAsrC252S·InsP6 (blue; PDB 3MMJ) structures demonstrates the intermediate position
of Ins(1,2,4,5,6)P5 relative to InsP6 and Ins(1,3,4,5)P4. The P-loop (yellow) and GA-loop
(cyan) are shown. The myo-inositol ring and only two of the phosphoryl/hydroxyl groups
are displayed to simplify the diagram.
In the PhyAsrC252S·InsP6 structure, the C2-phosphoryl group occupies the same Pa′
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Table 3.5: IP ring shifts relative to InsP5 in LSQ superposed structures (active site). Dis-
tances (A˚) between the C1 of InsP5 and the structurally equivalent carbons, the angles
between the plane of the 6-carbon rings, and the distances between the centres of mass of
the 6-carbon rings. The 6-carbon ring angle is the rotation angle between the planes of the
rings.
PhyAmmC250S/C548S
Ins(1,3,4,5)P4
1
PhyAsrC252S
InsP6
2
PhyAsrC252S
Ins(1,3,4,5)P4
3
PhyAsrC252S
Ins(1,4,5)P3
4
C6 distance 1.00 A˚ 0.41 A˚ 1.31 A˚ 1.33 A˚
6-carbon ring
18.5◦ -10.4◦ 21.0◦ 28.4◦
angle
6-carbon ring
0.60 A˚ 0.60 A˚ 0.80 A˚ 0.85 A˚
distance
1PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure: PDB 4WU3
2PhyAsrC252S·InsP6 structure: PDB 3MMJ
3PhyAsrC252S·Ins(1,3,4,5)P4 structure: PDB 4WTY
4PhyAsrC252S·Ins(1,4,5)P3 structure: PDB 4WU2
site, despite the C3-phosphoryl group location in the Ps site [166]. In order for the C2-
phosphoryl group to fill the Pa′ site when either the C3- or C4-phosphoryl group of InsP6 or
Ins(1,2,4,5,6)P5, respectively, is in the Ps site, there are compensatory changes in the C1-
C2-O2-P2 torsion angles (∼60◦ InsP6 and ∼140
◦ Ins(1,2,4,5,6)P5) that complement the
change in relative orientation of the myo-inositol ring within the active site (Figure 3.9). In
particular, the Ins(1,2,4,5,6)P5 myo-inositol ring is tilted and twisted towards the GA-loop
of PhyAmmC250S/C548S when compared to the PhyAsrC252S·InsP6 structure and the
Ins(1,2,4,5,6)P5 orientation relative to the GA-loop is intermediate to that in the InsP6 and
Ins(1,3,4,5)P4 structures (Table 3.5). This maximizes the number of favourable electrostatic
contacts with substrate as the Ps, Pa, Pb and Pa′ site account for virtually all direct contact in
the PhyAmmC250S/C548S·Ins(1,2,4,5,6)P5 and PhyAsrC252S·InsP6 complex structures.
Previous work has demonstrated that the PhyAsr active site is preformed and changes in
the myo-inositol ring orientation allow different IP substrates to optimize their use of the
existing phosphoryl-binding sites [166, 184]. This work demonstrates the C-terminal re-
peat of PhyAmm uses a similar mechanism to bind various IP substrates and suggests the
mechanism is common within the PTPLP family of enzymes.
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3.4.2 Residues stabilizing Ins(1,2,4,5,6)P5 binding to the C-terminal repeat diverge
from PhyAsr
The InsP6 hydrolysis pathway of the C-terminal repeat of PhyAmm and PhyAsr diverge
following the removal of the C3-phosphoryl group of InsP6, with PhyAmm removing the
C4-phosphoryl group and PhyAsr removing the C1-phosphoryl group of Ins(1,2,4,5,6)P5
[165, 184]. The position of the C4-phosphoryl group in the Ps site of the C-terminal repeat
of PhyAmm is consistent with the hydrolysis pathway that produces Ins(1,2,5,6)P4 from
the hydrolysis of Ins(1,2,4,5,6)P5 (Figures 3.4 and 3.7) [184]. Residue substitutions in the
two active sites that alter substrate contacts and likely influence substrate specificity include
Gln-549 and Asn-585 of PhyAmm, with Glu-253 and Phe-289 being the equivalent PhyAsr
residues (Figure 3.10). In PhyAmm, Gln-549 and Asn-585 provide favourable interactions
that stabilize the orientation and conformation of Ins(1,2,4,5,6)P5 within the active site and
facilitate the binding of the C4-phosphoryl in the Ps site. Glu-253 of PhyAsr is directed
away from the active site in both the presence and absence of bound ligands [162,166,184].
While this prevents a steric clash with bound InsP6, the same conformation is observed the
Ins(1,3,4,5)P4 complex structure where steric interaction should not be problematic. Given
the PhyAsr structures have been determined at the pH optima of the enzymes, it is likely
the Glu-253 carboxylate is anionic and the observed conformation removes an unfavourable
interaction with bound substrate. In the case of Asn-585, the structural equivalent Phe-289
of PhyAsr is incapable of providing a favourable electrostatic contact while decreasing the
accessibility of the Pa and Pb sites. As a result, Gln-549 and Asn-585 of PhyAmm provide
favourable interactions that stabilize the orientation and conformation of the substrate with
the C4-phosphoryl group in the Ps site while the equivalent residues in PhyAsr provide
none of the favourable interactions and potentially introduce unfavourable interactions.
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Figure 3.10: Superposition of the C-terminal repeat of the PhyAmmC250S/C548S·InsP5
structure and PhyAsr (PDB 4WTY) as a ribbon diagram with the ligand as sticks. Gln-548
and Asn-585 (red sticks) of the C-terminal repeat are visible and the structurally equivalent
Glu-253 and Phe-289 (blue sticks) of PhyAsr. Gln-549 makes additional interactions not
possible by Glu-253 due to side-chain conformation and also provides interactions with the
C3-hydroxyl. Asn-585 makes an additional contact with the C6-phosphoryl group bound in
the Pb site that the Phe-289 of PhyAsr is incapable of providing. These interactions stabilize
the conformation that results in positioning the C4-phosphoryl group of Ins(1,2,4,5,6)P5 for
hydrolysis.
3.4.3 Factors influencing the conformations of the variable loops
The Ω-loop, the β-hairpin (C-terminal repeat) and α-turn (N-terminal repeat) of the
Phy-specific domain, and the extended loop prior to the penultimate helix are all adjacent
to the active sites of PTPLPs and have been demonstrated to contribute to their specificity as
they vary in sequence identity, length and conformation [184]. These differences coupled
with the observation that the active-site residues that directly contact the IP ligands are
highly conserved, led to the hypothesis that the above variable loops are responsible for
specificity differences among PTPLPs. These loops are important in determining the size,
shape, and accessibility of the Pa/Pb and Pa′/Pb′ sides of the active sites, where the more
open and accessible the active site is the more relaxed substrate specificity is displayed by
the protein [184].
The quaternary structure of PhyAmm and PhyAsr directly influence the observed con-
formation of the extended loop (Pa/Pb side) and the β-hairpin turn of the Phy-specific do-
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main (Pa′/Pb′). In PhyAmm, the dimer interface includes an intermolecular contact between
the extended loop of the C-terminal repeat and the same loop of the N-terminal repeat (Fig-
ure 3.11 A). The two loops pack against one another and are indirectly stabilized by a
hydrogen bond, between Asp-295 and Arg-448, and a stacking interaction between Arg-
448 and Trp-599. These intermolecular interactions, pull the extended loop away from the
active site of the C-terminal repeat and increase accessibility to the Pa/Pb side of the ac-
tive site. The dimer interface in the PhyAsr homodimer is distinct from that observed in
PhyAmm and involves the β-hairpin turn of the Phy-specific domain (Figure 3.11 B). In par-
ticular, Asp-192 and Gly-193 of chain A and the identical residues of chain B are related
by an approximate 2-fold rotation that facilitates the formation of several intermolecular
main-chain hydrogen bonds. This interaction fixes the conformation of the β-hairpin and
allows the Asp-192 side chain to form a hydrogen bond with the i+1 main chain (Lys-187)
of the β-hairpin turn. These interactions pull the β-hairpin turn away from the active site
and increase the accessibility on the Pa′/Pb′ side of the PhyAsr active site.
In the case of the PhyAmm C-terminal repeat, the Pa/Pb side of the active site is rela-
tively accessible due to the conformation of the extended loop leaving more space as de-
scribed, while the Pa′/Pb′ side of the active site is relatively occluded due to the conforma-
tion of the β-hairpin turn extending over the Pb′ site (Figure 3.5). In the PhyAmmC250S/-
C548S·InsP5 complex structure, the C3-hydroxyl is bound on the relatively occluded Pa′/Pb′
side of the active site which is consistent with the proposed model. In the case of PhyAsr,
the extended loop prior to the penultimate helix extends over Pb while the β-hairpin turn
of the Phy loop is further from the active site. The model predicts the C3-hydroxyl will be
located on the relatively occluded Pa/Pb side of the active site which is compatible with the
C1-phosphoryl group specificity of PhyAsr for Ins(1,2,4,5,6)P5.
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Figure 3.11: Conformation of the variable loops of both PhyAmm and PhyAsr are influ-
enced by their quaternary structure. A, The dimer interface of PhyAmm includes con-
tacts between the extended loop prior to the penultimate helix of both the N-terminal (light
coloured loops) and C-terminal (dark coloured loops) repeats. The contacts are stabilized
by hydrogen bonds between Asp-295 and Arg-448, and stacking interactions between Arg-
448 and Trp-599. B, The dimer interface of PhyAsr involves the β-hairpin turn of the Phy-
specific domain with Asp-192 and Gly-193 participating in multiple main-chain hydrogen
bonds. Lys-187 forms a hydrogen bond with Asp-192 which locks the conformation of
the β-hairpin turn. The variable loops (colored segments) that influence substrate speci-
ficity include the extended loop prior to the penultimate helix (green), the extended Ω-loop
(red), and the β-hairpin and α turns (blue) within the Phy-specific domain. The active-
site GA-loops (cyan) and P-loops (yellow) are displayed with Ins(1,2,4,5,6)P5 (PhyAmm
C-terminal repeat) and InsP6 (PhyAsr) bound as black sticks to show protein orientation.
3.4.4 Substrate specificity of PhyAmm
The IP specificity assay accurately identifies the relative activities of the individual re-
peats of PhyAmm and their preferred IP substrates (Figure 3.7 and 3.8) [166, 184]. More
importantly, it strongly suggests they follow a “divide and conquer” approach to completely
hydrolyze InsP6. The highly active C-terminal repeat rapidly hydrolyzes InsP6 and the var-
ious InsP5 substrates while multiple InsP3 peaks accumulate throughout the time course
(Figure 3.8 B; Table 3.4). These InsP3 peaks accumulate to a greater extent than observed
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Figure 3.12: Variable loops implicated in the substrate specificity of PTPLPs. A, stereo
view of the superposition of N-terminal (green) and C-terminal (red) repeats of
PhyAmmC250S/C548S·Ins(1,2,4,5,6)P5 and PhyAsrC252S·InsP6 (red; PDB 3MMJ), as a
ribbon diagram with the ligand as sticks. The variable loops (colored segments) that in-
fluence substrate specificity include the extended loop prior to the penultimate helix, the
extended Ω-loop, and the β-hairpin (C-terminal repeat and PhyAsr) and α-turn (N-terminal
repeat) within the Phy-specific domain. B, the active site of the C-terminal repeat (red)
is relatively accessible (RA) on the Pa/Pb side and relatively occluded (RO) on the Pa′/Pb′
side. C, the PhyAsr active site (blue) is relatively occluded (RO) on the Pa/Pb side and
relatively accessible (RA) on the Pa′/Pb′ side. D, the active site of the N-terminal repeat
(green) is relatively accessible (RA) on the Pa/Pb side and relatively occluded (RO) on the
Pa′/Pb′ side.
for the fully active PhyAmm suggesting they are targeted by the N-terminal repeat. The IP
assay in the presence of the N-terminal repeat not only confirms its greatest activity is to-
wards these same peaks, it also demonstrates the N-terminal repeat has limited or no activity
towards the remaining peaks (Figure 3.8 C; Table 3.4). This novel assay also suggests the
N-terminal repeat has an additional substrate preference. In particular, it appears to prefer
InsP4 substrates that contain three adjacent phosphoryl groups and the axial C2-phosphoryl
group. This is demonstrated by the lack of activity towards the InsP4 substrates in peaks
18, 19 and 22 while peaks 14 to 17, 20 and 21 exhibit some activity (Figure 3.8 C and B.1;
Table 3.4). Peak 18 (DL-Ins(1,2,4,5)P4) lacks three adjacent phosphoryl groups while peak
19 (DL-Ins(1,3,4,5)P4) and peak 22 (DL-Ins(1,4,5,6)P4) lack an axial C2-phosphoryl. The
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only IP lacking an axial C2-phosphoryl not included in this list is Ins(1,3,4,6)P4 which over-
laps peak 16 (DL-Ins(1,2,3,6)P4). The remaining InsP4 peaks all contain both a C2-phos-
phoryl group and three adjacent phosphoryl groups. While the C-terminal repeat may show
a slight preference for IPs containing an axial C2-phosphoryl group, the high activity of
this repeat limits the detection of additional substrate preferences under the present reac-
tion conditions.
3.4.5 InsP6 specificity of the N-terminal repeat
The InsP6 hydrolysis pathway of the individual repeats of PhyAmm generate the same
peaks as judged by HPIC (Figure 3.7). However, we must point out that this technique
cannot separate all myo-inositol enantiomers as indicated by their designation as DL-Ins-
(1,2,4,5,6)P5 and DL-Ins(1,2,5,6)P4 [48, 161]. In the case of the C-terminal repeat and
PhyAsr, the precise enantiomer is known from crystallographic complex structures and
has been confirmed for PhyAsr by alternative methods [165, 166, 184]. Consequently,
PhyAsr and the C-terminal repeat are known to generate Ins(1,2,4,5,6)P5 and are classi-
fied as 3-phytases. In the case of the N-terminal repeat, the DL-Ins(1,2,4,5,6)P5 enantiomer
generated from InsP6 hydrolysis has yet to be identified. Based on the observed accessi-
bility within the N-terminal repeat active site and differences in the Pa and Pa′ sites, we
suggest the N-terminal repeat is a 1-phytase that produces Ins(2,3,4,5,6)P5.
The active sites of the N- and C-terminal repeats differ in size, shape and residue com-
position. As a result of these differences, the Pa′/Pb′ side of the N-terminal repeat active
site has less available space and the Pa/Pb side has more available space than observed in
the C-terminal repeat. Consequently, the available space on each side of the active site
of the N-terminal repeat is opposite that observed in PhyAsr and represents a more ex-
treme version of the accessibility observed in the C-terminal repeat (Figure 3.12). The
relatively occluded Pa′/Pb′ side of the active site is likely responsible for the lack of activ-
ity of the N-terminal repeat towards InsP6 and InsP5 substrates as superpositions of the N-
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and C-terminal repeats, and similar superpositions with PhyAsr suggest that highly phos-
phorylated substrates such as InsP6 and InsP5 will form too close contacts on this side of
the active site (Figures 3.5 and 3.6). At the same time, conformational differences in the
extended loop prior to the penultimate helix and the substitution of Gly-301, for Lys-600 of
the C-terminal repeat, opens a large space adjacent to the GA-loop on the Pa/Pb side of the
active site of the N-terminal repeat that can accommodate the axial C2-phosphoryl group.
In addition to changes in active-site accessibility, residue substitutions in the N-terminal
repeat active site significantly reduce the number of contacts within the Pa′ site (Table 3.3).
Specifically, three potential hydrogen bonding interaction are lost as Arg-351 and Gln-549
of the C-terminal repeat are replaced by Lys-59 and Tyr-251, respectively. Finally, the
presence of the bulky Met-254 of the N-terminal repeat P-loop forms close contacts with
phosphoryl groups bound to the Pb site in superpositions with the PhyAsrC252S·InsP6 and
PhyAmmC250S/C548S·Ins(1,2,4,5,6)P5 structures. This suggests that the Pa and Pb sites
of the N-terminal repeat are shifted towards the GA-loop. This would allow an axial C2-
phosphoryl group to fill the Pa site, interact with the GA-loop after a small reorientation
of the myo-inositol ring, and minimize steric interaction within the Pa′ and Pb′ sites. Each
of the above differences in the size and shape of the N-terminal repeat active site suggest
the axial C2-phosphoryl of InsP6 can be accommodated within the Pa site, consistent with
1-phytase activity.
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Conclusions and future directions
4.1 Overview
Protein tyrosine phosphatase-like myo-inositol phosphatases (PTPLPs) are bacterial en-
zyme members of the protein tyrosine phosphatase (PTP) superfamily [162, 165]. In eu-
karyotes, PTPs remove phosphoryl groups from phosphorylated proteins, contributing to
the regulation of a wide variety of signal transduction pathways [188, 189]. Originally
named for their activity towards proteins containing phosphotyrosine residues, variants of
classic PTPs are known to target phosphoserine and phosphothreonine containing proteins
and serve as transmembrane receptors involved in cell-cell communication [188,190]. Un-
like other known PTPs, PTPLPs typically have little or no activity towards phosphoproteins
and preferentially hydrolyze myo-inositol phosphates (IPs), an important family of eukary-
otic metabolites [2,157,158,160,161,165,170]. These compounds have an enormous array
of activities in biological systems from cofactors and second messengers to phosphorus
storage compounds and lipid components [2, 18, 19].
PTPLPs were originally detected and identified in rumen bacteria as enzymes with high
activity towards InsP6 (or phytate), and represent the fourth structural class of microbial
myo-inositol phosphatases (IPases) [114, 154, 162]. Microbial IPases have important agri-
cultural applications and are commonly used as grain based diet feed supplements where
they increase the availability of inorganic phosphate and myo-inositol, and decrease phos-
phate pollution [103,114–117]. Consequently, initial research involving PTPLPs examined
their nutritional applications and targeted highly-active enzymes believed to be phosphate
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scavengers [154, 156]. Subsequent research has shown multiple PTPLPs are present in
microbial pathogens where they are believed to selectively inhibit signal transduction path-
ways [159–161]. More recently, gut microbes expressing IPases have been shown to alter
calcium mobilization in host epithelial cells, suggesting interkingdom cell-cell communi-
cation [183]. Clearly, the discovery of each additional biological function suggests the
PTPLPs, and IPases in general, are more than simple phosphate scavengers.
Finally, PTPLPs sequentially remove phosphoryl groups from InsP6, the only abun-
dant IP in the environment, via enzyme-specific pathways [157, 158, 165, 170]. For exam-
ple, PhyAsr removes the C3-phosphoryl from InsP6, the C1-phosphoryl from the resulting
Ins(1,2,4,5,6)P5, followed by the C6-phosphoryl from Ins(2,4,5,6)P4, the C5-phosphoryl
from Ins(2,4,5)P3 and finally the C4-phosphoryl from Ins(2,4)P2 [165]. While PhyAsr
does not have a strict specificity for these IPs, in the presence of saturating concentrations
of InsP6 more than 85% of the starting material is hydrolyzed by this pathway. Other
characterized PTPLPs have distinct pathways and include the only known IPase to remove
the C1-phosphoryl group and one of only two shown to remove the C5-phosphoryl from
InsP6 [157, 158, 161,165,170,184].
4.2 Summary
In Chapter 2, I present structures of the PTPLP from Selenomonas ruminantium (PhyAsr)
in complex with Ins(1,3,4,5)P4 and Ins(1,4,5)P3, and the PTPLP fromMitsuokella multacida
(PhyAmm) in complex with Ins(1,3,4,5)P4. These represent the first PTPLP structures
in complex with InsP4 and InsP3 substrates and the first complex structure of PhyAmm.
The IPs bind to each of the proteins using phosphoryl-binding sites that were initially
identified in the structure of PhyAsr in complex with InsP6. Further, PhyAsr and the
PhyAmm C-terminal repeat bind Ins(1,3,4,5)P4 in identical conformations utilizing con-
served residues. These complex structures demonstrate that there are no conformational
changes upon substrate binding regardless of the phosphorylation level of the substrate.
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However, there is a marked difference between the myo-inositol ring orientations of the
Ins(1,3,4,5)P4 and Ins(1,4,5)P3 substrates when compared to InsP6. The changes in myo-
inositol ring orientation allow these substrates to utilize the identified phosphoryl-binding
sites without changes to the preformed active site. The hydrolysis pathway of PhyAmm
was determined and demonstrates that PhyAsr and PhyAmm have divergent specificities
for the Ins(1,2,4,5,6)P5, with PhyAsr producing Ins(2,4,5,6)P4 and PhyAmm producing
Ins(1,2,5,6)P4. The distinct substrate specificity of these enzymes and the conserved inter-
actions they make with Ins(1,3,4,5)P4 suggests that structural features that do not directly
contact the bound substrate influence substrate specificity. Three structural features that
vary in sequence composition, length, and conformation were identified: the extended loop
prior to the penultimate helix, the Ω-loop, and a β-hairpin turn of the Phy-specific domain.
A simple hypothesis suggests the available space within the active site affects substrate
specificity, which was confirmed by determining the InsP6 hydrolysis pathway of the PT-
PLP from Bdellovibrio bacteriovorus (PhyAbb). PhyAbb has large deletions in several of
these loops and demonstrates a broad specificity towards Ins(1,2,4,5,6)P5 by producing four
different InsP4 products.
In Chapter 3, I present the structure of PhyAmm in complex with Ins(1,2,4,5,6)P5 that
represents the first complex of a PTPLP with an InsP5 and the first of an IP along the InsP6
hydrolysis pathway. I have also presented the first IP specificity assay. In this assay, IPs
are produced by a partial acid hydrolysis of InsP6 and are then incubated with the protein.
By producing a time-course of the enzyme hydrolysis reaction, observations can be made
about the activity of the protein against the various IPs. In the case of PhyAmm, it is evident
that the two repeats have divergent activities towards the IPs, with the N-terminal repeat
having higher activity towards InsP4 and InsP3 substrates, while the C-terminal repeat has
the highest activity towards InsP6 and InsP5 substrates. In addition, this novel assay clearly
demonstrates the N-terminal repeat has its greatest activity towards IPs that accumulate
in the presence of the C-terminal repeat. This clearly indicates the two repeats have a
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“divide and conquer” approach to maximizing phosphoryl group removal from InsP6 and
mixed IPs. This work further confirms the hypothesis that the variable loops adjacent to the
active site are influencing substrate specificity and elaborates on the structural features of
PhyAmm and PhyAsr that confer the conformation of these loops.
4.3 PTPLPs for producing IPs
IPs are particularly challenging to purify or synthesize due to their low abundance and
large number of stereoisomers, respectively, and only a small subset of known IPs are com-
mercially available [22]. PTPLPs are capable of producing InsP5, InsP4, InsP3, InsP2 and
Ins(2)P products when supplied with InsP6 [157, 158, 161, 165, 170]. Of special interest is
that the PTPLPs characterized to date have unique InsP6 hydrolysis pathways and activities
toward the various IPs. As the number of and our knowledge of PTPLPs increases, there
is the potential to produce any IP by engineering the proteins to produce the specific prod-
uct. Producing IPs that are currently unavailable will likely lead to additional discoveries
regarding the biological roles of this family of metabolites. As it is, the characterized PT-
PLPs can be used to produce large quantities of IPs that are currently unavailable by halting
the enzyme when the target IP is produced.
To better our knowledge of PTPLPs, increasing our understanding of the structural fea-
tures that contribute to the substrate specificity will aid in our ability to identify a PTPLP
that produces a desired IP, or to engineer one. Ultimately, the ability to accurately predict
substrate specificity from primary sequence information would be an invaluable tool. As
this work represents the first examples of PTPLPs in complex with an InsP4, InsP3, or an
IP along a hydrolysis pathway, it would be beneficial to produce additional complex struc-
tures. Of special interest would be to produce PhyAsr and PhyAmm in complex with an
on-pathway InsP4 or InsP3 so that 1) we would see if the structural features that distinguish
the InsP5 specificity translate to the other substrates, and 2) we could identify the contacts
that the N-terminal repeat makes when in complex with an IP. Additional complex struc-
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tures of other members of the PTPLP class of IPases would provide additional information
about the structural features that have been identified in this work. Of particular interest
would be PhyAbb and the PTPLP from Legionella pneumophila (PhyAlp) as their crystal
structures have been determined making them strong candidates for producing a successful
complex structure [159, 160]. Further, these proteins have larger variations in their PTPLP
specific loops and residues that are predicted to interact with the substrates than PhyAmm
and PhyAsr and would provide great insight into the function of these features.
4.4 Functions of PTPLPs
With their broad specificity and presence in rumen organisms, PhyAmm and PhyAsr
have been predicted to function as phosphate scavengers [154, 155]. A myo-inositol phos-
phatase (IPase) from the prominent human gut bacteria Bacteroides thetaiotaomicron (Bt-
Minpp) is packaged into outer membrane vesicles (OMVs) to prevent degradation from pro-
teases within the gut [183]. Interestingly, BtMinpp-OMVs have been shown to interact with
epithelial cells to promote intracellular calcium signalling. As both PhyAsr and PhyAmm
are associated with the outer membrane, it is possible that with more studies, a similar cross-
kingdom cell-to-cell signalling as seen with BtMinpp will be identified [155,157,159,160].
The N-terminal repeat of PhyAmm displays structural features that indicate it possibly
removes the C1-phosphoryl group from InsP6. Due to the inability to distinguish between
enantiomers via HPIC, further studies must be conducted to determine the InsP6 specificity
of the N-terminal repeat. Interestingly, the first PTPLP specific for the C1-phosphoryl
group of InsP6 (1-phytase) has been identified in the pathogenic organism Xanthamonas
campestris pv. vesicatoria (XopH) [161]. In addition to the unique C1-phosphoryl group
specificity, XopH does not hydrolyze the Ins(2,3,4,5,6)P5 product, unlike the other PT-
PLPs characterized to date. Further biochemical characterizations of XopH revealed that,
though it does not hydrolyze the InsP5 it produces, it successfully hydrolyzed the other
five InsP5 isomers. This indicates XopH is not functioning as a scavenging enzyme, sug-
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gesting the Ins(2,3,4,5,6)P5 product directly or indirectly affects the host organism during
Xanthomonas infections and clearly demonstrates the importance of PTPLP substrate speci-
ficity. The IP specificity assay would help determine if XopH has narrow specificity towards
IPs or if it is capable of hydrolyzing some or all of lesser phosphorylated forms revealing
other possible cellular targets. The novel IP hydrolysis assay in the presence of a mixture
of IPs is an obvious tool to rapidly identify the substrate specificity of PTPLPs. In turn, this
information would allow research programs to target specific PTPLPs with unique specifici-
ties and more rapidly advance our understanding of this class of enzyme. Structural studies
targeting pathogen PTPLPs are ongoing and aimed at generating complex structures that
can be utilized to understand the structural determinants that govern their substrate speci-
ficity. Recently, a novel class of PTPLP containing an additional glycosyl hydrolase domain
has been identified in Clostridia. Very little is known about these enzymes making them
interesting candidates for both structural studies and our IP hydrolysis assay.
As interest in IPases initially arose in the field of nutrition, it is natural to ask if PTPLPs
potentially have a role in human or animal nutrition. PTPLPs have favourable pH profiles
and high catalytic efficiency; however, their application is restricted due to the nature of
their catalytic mechanism [162–165, 168, 169]. The thiolate of the catalytic cysteine can
be irreversibly oxidized leading to enzyme inactivation [168]. A possible remedy would
be to modify the enzyme active site according to other PTP members that exhibit a lower
tendency to oxidization or higher ability to reverse oxidation [114, 191]. As the under-
standing of PTPLPs increases, genetically engineering them to exhibit a lower tendency to
oxidation or higher ability to reverse oxidation will be more effective. As a result, PTPLPs
would become better candidates as feed additives. A large variety of PTPLPs are still being
discovered and a better candidate than those we currently know may still arise.
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Appendix A
A.1 Identification of PhyAsr, PhyAmm and PhyAbb hydrolysis prod-
ucts
Hydrolysis of 10 mM InsP6 (Sigma-Aldrich) was carried out at room temperature in
the presence of 50 nM wild type PhyAsr and PhyAmm, and 100 nM wild type PhyAbb in
50 mM Na-acetate pH 5.0, 300 mM NaCl, 5 mM BME, 0.1 mM EDTA. Aliquots of 100 µL
were taken, quenched with 5% trichloroacetic acid and subjected to HPIC (Waters 1525
Binary HPIC Pump; Milford, MA) utilizing a CarboPac PA-100 (4 x 240 mm) analytical
column (Dionex; Sunnyvale, CA) [179], at room temperature using a post-column reactor
flow rate of 0.2 mL/min. The reference sample was produced by following the methodology
of Blaabjerg et al. (2010) [179]. Briefly, partial hydrolysis of InsP6 was performed by
boiling 1.5 g InsP6 with 100 mL of 0.5 M HCl for 11 hours. The solution was evaporated
to dryness and the residue was dissolved to 100 mg/mL. Peak assignment was performed
by referencing the chromatograms to the peak identities determined by Blaabjerg et al.
(2010) [179]. Spiking experiments were performed by mixing the reference sample (30%)
and the hydrolysis product (70%) of PhyAsr (30 minute time point), PhyAmm (60 minute
time point) and PhyAbb (60 minute time point).
A.2 Figures and tables
Table A.1: Pairwise RMSD comparison of least squares (LSQ) superposition of the
PhyAsrC252S monomer alone and in complex with IPs. RMSDs (A˚) for the monomer
main- (mc; 1248 atoms) and side-chain (sc; 1293 atoms) atoms are shown. In all cases,
chain A of the indicated structures were used in the comparison. The main-chain confor-
mation of these structures are essentially identical as the RMSDs are comparable to the
co-ordinate errors in the structure determinations.
InsP6
2 Ins(1,3,4,5)P4
3 Ins(1,4,5)P3
4
mc sc mc sc mc sc
Apo1 0.14 0.57 0.18 0.87 0.22 0.77
InsP6
2 0.19 0.86 0.21 0.64
Ins(1,3,4,5)P4
3 0.19 0.77
1PhyAsr wild-type structure: PDB 2PSZ
2PhyAsrC252S·InsP6 structure: PDB 3MMJ
3PhyAsrC252S·Ins(1,3,4,5)P4 structure: PDB 4WTY
4PhyAsrC252S·Ins(1,4,5)P3 structure: PDB 4WU2
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Table A.2: Pairwise RMSD comparison of LSQ superposition of the PhyAsrC252S active
site alone and in complex with IPs. Main- (mc; 148 atoms) and side-chain (sc; 182 atoms)
RMSDs (A˚) of the active-site residues are shown. In all cases, chain A of the indicated
structures were used in the comparison.
InsP6
2 Ins(1,3,4,5)P4
3 Ins(1,4,5)P3
4
mc sc mc sc mc sc
Apo1 0.13 0.36 0.19 0.57 0.18 0.44
InsP6
2 0.17 0.50 0.14 0.28
Ins(1,3,4,5)P4
3 0.12 0.49
1PhyAsr wild-type structure: PDB 2PSZ
2PhyAsrC252S·InsP6 structure: PDB 3MMJ
3PhyAsrC252S·Ins(1,3,4,5)P4 structure: PDB 4WTY
4PhyAsrC252S·Ins(1,4,5)P3 structure: PDB 4WU2
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Table A.3: Pairwise RMSD (A˚) comparison of LSQ superposition of the PhyAmm monomers from the P21, and P1 space groups, in
complex with Ins(1,3,4,5)P4 (PDB 4WU3) and without (apo; PDB 3F41). Superpositions were performed using amino acids 47 to 636
(m; 2360 atoms), 47 to 342 (n; 1184 atoms) and 343 to 636 (c; 1176 atoms).
Apo
Chain B
Ins(1,3,4,5)P4
Chain A
Ins(1,3,4,5)P4
Chain B
Ins(1,3,4,5)P4
Chain C
Ins(1,3,4,5)P4
Chain D
m n c m n c m n c m n c m n c
Apo
Chain A 0.64 0.28 0.38 0.51 0.38 0.38 0.46 0.36 0.40 0.50 0.41 0.38 0.57 0.35 0.39
Ins(1,3,4,5)P4
Chain A 0.68 0.38 0.43 0.59 0.36 0.42 0.70 0.40 0.43 0.42 0.35 0.38
Ins(1,3,4,5)P4
Chain B 0.26 0.16 0.27 0.12 0.13 0.09 0.43 0.16 0.30
Ins(1,3,4,5)P4
Chain C 0.25 0.13 0.27 0.30 0.16 0.18
Ins(1,3,4,5)P4
Chain D 0.45 0.19 0.319
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Table A.4: Pairwise RMSD comparison of LSQ superposition of the C-terminal repeat
active site of PhyAmmC250S/C548S in complex with Ins(1,3,4,5)P4 (PDB 4WU3) and
without (PDB 3F41). Main- (mc; 184 atoms) and side-chain (sc; 216 atoms) RMSDs (A˚)
of the active-site residues are shown. The main-chain conformation of these structures are
essentially identical as the RMSDs are comparable to the co-ordinate errors in the structure
determinations.
Apo
Chain B
Ins(1,3,4,5)P4
Chain A
Ins(1,3,4,5)P4
Chain B
Ins(1,3,4,5)P4
Chain C
Ins(1,3,4,5)P4
Chain D
mc sc mc sc mc sc mc sc mc sc
Apo
Chain A 0.21 0.49 0.19 0.34 0.18 0.34 0.19 0.35 0.17 0.34
Ins(1,3,4,5)P4
Chain A 0.30 0.57 0.27 0.56 0.30 0.58 0.22 0.53
Ins(1,3,4,5)P4
Chain B 0.12 0.16 0.07 0.10 0.14 0.20
Ins(1,3,4,5)P4
Chain C 0.11 0.14 0.11 0.14
Ins(1,3,4,5)P4
Chain D 0.15 0.19
Table A.5: Less-phosphorylated IP ring shifts relative to InsP6 (PDB 3MMJ) in LSQ super-
posed structures (active site). Distances (A˚) between the C6 of InsP6 and the structurally
equivalent carbons, the angles between the plane of the 6-carbon rings, and the distances
between the centres of mass of the 6-carbon rings. The 6-carbon ring angle is the rotation
angle between the planes of the rings.
Ins(1,3,4,5)P4
1 Ins(1,4,5)P3
2
C6 Distance 1.53 A˚ 1.51 A˚
6-carbon ring angle 30.79◦ 36.66◦
6-carbon ring distance 1.24 A˚ 1.25 A˚
1PhyAsrC252S·Ins(1,3,4,5)P4 structure: PDB 4WTY
2PhyAsrC252S·Ins(1,4,5)P3 structure: PDB 4WU2
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Figure A.1: Identification of products from the hydrolysis of InsP6 by PhyAsr and
PhyAmm. (A) Chromatogram of the reference samples produced by an 11 hour
acid hydrolysis as performed by and identified by Blaabjerg et al. (2010) [179].
The peaks are identified as: (14) Ins(1,2,3,5)P4, (15) DL-Ins(1,2,4,6)P4, (16) DL-
Ins(1,2,3,6)P4, (17) Ins(1,3,4,6)P4, (18) DL-Ins(1,2,4,5)P4, (19) DL-Ins(1,3,4,5)P4, (20)
DL-Ins(1,2,5,6)P4, (21) Ins(2,4,5,6)P4, (22) DL-Ins(1,4,5,6)P4, (23) Ins(1,2,3,4,6)P5, (24)
DL-Ins(1,2,3,4,5)P5, (25) DL-Ins(1,2,4,5,6)P5, (26) Ins(1,3,4,5,6)P5, (27) InsP6. (B) Iden-
tification of the PhyAsr hydrolysis product by incubating 50 nM wild type PhyAsr with
10 mM InsP6 for 30 minutes (red), spiked with 30 g/L of the reference sample (blue) and
the reference sample (30 g/L; black). (C) Identification of the PhyAmm hydrolysis product
by incubating 50 nM wild type PhyAmm with 10 mM InsP6 for 60 minutes (red), spiked
with 30 g/L of the reference sample (blue) and the reference sample (30 g/L; black). (D)
Identification of the PhyAbb hydrolysis product by incubating 100 nM wild type PhyAbb
with 10 mM InsP6 for 60 minutes (red), spiked with 30 g/L of the reference sample (blue)
and the reference sample (30 g/L; black). The IPs were separated using a CarboPac PA-
100 analytical column with a methanesulfonic acid gradient [179]. IPs were visualized
using a post-column reactor with 0.1% (m/v) Fe(NO3)3 in a 2% (m/v) HClO4 solution (0.2
mL/min).
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B.1 Figures and tables
Table B.1: Pairwise RMSD (A˚) comparison of LSQ superposition of the PhyAmm
monomers from the InsP5 (P1), Ins(1,3,4,5)P4 (P1) and apo (without substrate; P21) struc-
tures. Main-chain atom superpositions were performed using amino acids 47 to 636 (m;
2360 atoms), 47 to 342 (n; 1184 atoms) and 343 to 636 (c; 1176 atoms).
Ins(1,3,4,5)P4
2 Apo3
m n c m n c
Ins(1,2,4,5,6)P5
1 0.33 0.27 0.31 0.53 0.44 0.47
Ins(1,3,4,5)P4
2 0.51 0.38 0.38
1PhyAmmC250S/C548S·InsP5 structure
2PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure: PDB 4WU3
3PhyAmm Apo structure: PDB 3F41
Table B.2: Pairwise RMSD comparison of LSQ superposition of the C-terminal repeat ac-
tive site of PhyAmmC250S/C548S alone and in complex with InsP5 and Ins(1,3,4,5)P4.
Main- (mc; 164 atoms) and side-chain (sc; 194 atoms) RMSDs (A˚) of the active-site
residues are shown. The main-chain conformation of these structures are essentially identi-
cal as the RMSDs are comparable to the co-ordinate errors in the structure determinations.
Ins(1,3,4,5)P4
2 Apo3
mc sc mc sc
Ins(1,2,4,5,6)P5
1 0.22 0.50 0.25 0.59
Ins(1,3,4,5)P4
2 0.18 0.46
1PhyAmmC250S/C548S·InsP5 structure
2PhyAmmC250S/C548S·Ins(1,3,4,5)P4 structure: PDB 4WU3
3PhyAmm Apo structure: PDB 3F41
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Figure B.1: HPIC chromatograms of the activities PhyAmmC548S against the 11 hour
acid hydrolysis mixture. The PhyAmmC548S at 200 nM was incubated with 20 mg/mL
of the 11 hour acid hydrolysis for 60 min (cyan). Production of the 11 hour acid
hydrolysis sample (black) as performed previously [179, 184]. The peaks are iden-
tified by Blaabjerg et al. (2010) [179] as: (1-5) InsP2, (6-11) InsP3, (12) DL-
Ins(1,5,6)P3, (13) DL-Ins(4,5,6)P3, (14) Ins(1,2,3,5)P4, (15) DL-Ins(1,2,4,6)P4, (16) DL-
Ins(1,2,3,6)P4, (17) Ins(1,3,4,6)P4, (18) DL-Ins(1,2,4,5)P4, (19) DL-Ins(1,3,4,5)P4, (20)
DL-Ins(1,2,5,6)P4, (21) Ins(2,4,5,6)P4, (22) DL-Ins(1,4,5,6)P4, (23) Ins(1,2,3,4,6)P5, (24)
DL-Ins(1,2,3,4,5)P5, (25) DL-Ins(1,2,4,5,6)P5, (26) Ins(1,3,4,5,6)P5, (27) InsP6. The IPs
were separated using a CarboPac PA-100 analytical column with a methanesulfonic acid
gradient [179, 184]. IPs were visualized using a post-column reactor with 0.1% (m/v)
Fe(NO3)3 in a 2% (m/v) HClO4 solution (0.2 mL/min).
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